https://www.dermfield.com/ hourly 1.0 https://www.dermfield.com/search monthly 0.3 https://www.dermfield.com/privacy monthly 0.3 https://www.dermfield.com/terms monthly 0.3 https://www.dermfield.com/cookies monthly 0.3 https://www.dermfield.com/disclaimer monthly 0.3 https://www.dermfield.com/editorial monthly 0.3 https://www.dermfield.com/advertising monthly 0.3 https://www.dermfield.com/contacts monthly 0.3 https://www.dermfield.com/about monthly 0.3 https://www.dermfield.com/dmca monthly 0.3 https://www.dermfield.com/categories/clinical-dermatology hourly 0.8 https://www.dermfield.com/categories/inflammatory-disease hourly 0.8 https://www.dermfield.com/categories/skin-cancer hourly 0.8 https://www.dermfield.com/categories/aesthetics hourly 0.8 https://www.dermfield.com/categories/cosmeceuticals hourly 0.8 https://www.dermfield.com/categories/research-briefs hourly 0.8 https://www.dermfield.com/categories/therapeutics hourly 0.8 https://www.dermfield.com/categories/practice-policy hourly 0.8 https://www.dermfield.com/categories/industry-regulation hourly 0.8 https://www.dermfield.com/articles/contemporary-pediatrics-takes-on-the-food-allergyeczema-question-0d8a9187 2026-10-12T18:10:04.359Z daily 0.9 https://www.dermfield.com/articles/systematic-review-delivers-reality-check-on-topical-skin-biotics-5113d4cc 2026-10-12T17:40:05.084Z daily 0.9 https://www.dermfield.com/articles/beauty-is-drifting-into-medicine-dermatology-should-pay-attention-e854aad0 2026-10-12T17:40:05.078Z daily 0.9 https://www.dermfield.com/articles/glp-1-combination-therapy-signals-new-benefits-in-psoriasis-5e2765f9 2026-10-12T17:10:03.744Z daily 0.9 https://www.dermfield.com/articles/osteoclast-like-giant-cells-flagged-in-rare-atypical-fibroxanthoma-variant-4d1baa97 2026-10-12T16:50:03.819Z daily 0.9 https://www.dermfield.com/articles/medicare-payments-for-dermatology-procedures-fall-29-aa955859 2026-10-12T16:50:03.810Z daily 0.9 https://www.dermfield.com/articles/coal-tar-shampoo-for-dandruff-a-dermatologist-s-view-576a550e 2026-10-12T15:10:03.750Z daily 0.9 https://www.dermfield.com/articles/glp-1-drugs-may-ease-psoriasis-in-some-patients-study-finds-13a86e7e 2026-10-12T15:10:03.742Z daily 0.9 https://www.dermfield.com/articles/lilly-s-zepbound-boosts-taltz-response-in-psoriasis-study-c91673c2 2026-10-12T12:40:03.415Z daily 0.9 https://www.dermfield.com/articles/case-report-puts-late-onset-plaque-psoriasis-in-older-adults-in-focus-d34ce283 2026-10-12T12:35:03.504Z daily 0.9 https://www.dermfield.com/articles/biologic-safety-myths-in-elderly-psoriasis-patients-under-scrutiny-254db4c6 2026-10-12T12:35:03.504Z daily 0.9 https://www.dermfield.com/articles/hidradenitis-suppurativa-claims-data-reveal-sex-parity-and-rural-care-gaps-0a5d91f8 2026-10-12T12:35:03.504Z daily 0.9 https://www.dermfield.com/articles/debunking-biologic-safety-myths-in-elderly-psoriasis-patients-7f6ce459 2026-10-12T12:35:03.488Z daily 0.9 https://www.dermfield.com/articles/palvella-puts-u-s-dsap-population-at-154-986-in-new-posters-28bfb311 2026-10-12T12:05:03.528Z daily 0.9 https://www.dermfield.com/articles/social-media-driven-cosmetic-use-tied-to-barrier-damage-and-delayed-acne-treatme-c9b0a4d8 2026-10-12T12:05:03.544Z daily 0.9 https://www.dermfield.com/articles/palvella-brings-clinical-and-claims-data-to-dermatology-conference-stage-5491aa0e 2026-10-12T12:05:03.544Z daily 0.9 https://www.dermfield.com/articles/palvella-to-present-three-posters-on-microcystic-lymphatic-malformations-and-dsa-a3fccbeb 2026-10-12T12:05:03.544Z daily 0.9 https://www.dermfield.com/articles/enfortumab-vedotin-reactions-reclassified-as-tec-not-ten-7efa421e 2026-10-12T11:15:03.334Z daily 0.9 https://www.dermfield.com/articles/pemphigus-vulgaris-therapy-pipeline-expands-beyond-rituximab-3f931772 2026-10-12T10:05:03.378Z daily 0.9 https://www.dermfield.com/articles/dermdox-group-acquires-modern-aesthetics-plastic-surgery-f7948ed2 2026-10-12T10:05:03.363Z daily 0.9 https://www.dermfield.com/articles/dermatologists-lay-out-evidence-based-paths-for-treating-facial-and-body-scars-dc394cb4 2026-10-12T10:05:03.378Z daily 0.9 https://www.dermfield.com/articles/pdrn-in-topical-skin-care-what-the-evidence-actually-supports-9704a948 2026-10-12T08:45:03.239Z daily 0.9 https://www.dermfield.com/articles/regional-medicare-contractors-quietly-shape-us-dermatology-care-31976b80 2026-10-12T08:05:03.200Z daily 0.9 https://www.dermfield.com/articles/acrotech-launches-adquey-enters-u-s-dermatology-market-8a046adc 2026-10-12T07:30:03.242Z daily 0.9 https://www.dermfield.com/articles/lilly-reports-taltz-zepbound-combo-beats-taltz-alone-in-psoriasis-study-14efebb1 2026-10-12T07:30:03.233Z daily 0.9 https://www.dermfield.com/articles/university-of-miami-launches-aesthetic-medicine-certificate-79dd0cbc 2026-10-12T06:00:03.107Z daily 0.9 https://www.dermfield.com/articles/biofrontera-files-snda-to-broaden-ameluz-pdt-label-for-actinic-keratoses-c7c365e5 2026-10-12T05:00:03.019Z daily 0.9 https://www.dermfield.com/articles/icotrokinra-sustains-psoriasis-skin-clearance-through-2-years-0bb408da 2026-10-12T02:55:02.925Z daily 0.9 https://www.dermfield.com/articles/merz-aesthetics-accelerates-expansion-as-aesthetics-demand-surges-8ea833cb 2026-10-12T01:25:02.701Z daily 0.9 https://www.dermfield.com/articles/optimizing-hidradenitis-suppurativa-care-biologics-combos-surgery-14671fa1 2026-10-12T00:55:02.620Z daily 0.9 https://www.dermfield.com/articles/glp-1-combination-therapy-signals-new-benefits-in-psoriasis-0cab33f6 2026-10-11T23:55:02.552Z daily 0.9 https://www.dermfield.com/articles/review-reframes-ad-and-psoriasis-as-dynamic-immune-processes-91edc439 2026-10-11T23:55:02.552Z daily 0.9 https://www.dermfield.com/articles/systematic-review-probes-immune-link-between-childhood-obesity-and-eczema-7d7899fe 2026-10-11T23:55:02.537Z daily 0.9 https://www.dermfield.com/articles/wiley-review-maps-herbal-bioactives-in-atopic-dermatitis-care-0a37f15b 2026-10-11T23:55:02.552Z daily 0.9 https://www.dermfield.com/articles/fine-particulate-matter-linked-to-atopic-dermatitis-kyung-hee-study-finds-8e2c6372 2026-10-11T22:55:02.451Z daily 0.9 https://www.dermfield.com/articles/hugel-backs-physician-led-research-to-raise-k-aesthetics-profile-1d6ff8c6 2026-10-11T22:25:02.394Z daily 0.9 https://www.dermfield.com/articles/denifanstat-sustains-acne-improvement-through-52-weeks-in-phase-3-extension-26be44b8 2026-10-11T22:20:02.397Z daily 0.9 https://www.dermfield.com/articles/oral-antibiotics-and-retinoids-in-acne-how-clinicians-are-rethinking-selection-f3de5c9f 2026-10-11T20:20:02.274Z daily 0.9 https://www.dermfield.com/articles/epigenomic-ctdna-assay-predicts-recurrence-in-resected-melanoma-81df1ade 2026-10-11T19:50:02.204Z daily 0.9 https://www.dermfield.com/articles/skin-microbiota-remodels-dynamically-across-homeostasis-and-wound-repair-34f09ce2 2026-10-11T19:20:02.160Z daily 0.9 https://www.dermfield.com/articles/two-thirds-of-atopic-dermatitis-patients-misdiagnosed-report-finds-a1c5063e 2026-10-11T18:50:02.285Z daily 0.9 https://www.dermfield.com/articles/early-psoriatic-arthritis-screening-can-prevent-irreversible-damage-2c21733d 2026-10-11T17:50:02.082Z daily 0.9 https://www.dermfield.com/articles/hs-management-spotlighted-comorbidities-expectations-wound-care-d35bfcee 2026-10-11T17:15:02.031Z daily 0.9 https://www.dermfield.com/articles/denifanstat-shows-deeper-acne-results-through-52-weeks-1371a873 2026-10-11T14:44:57.895Z daily 0.9 https://www.dermfield.com/articles/hybrid-optimizer-sharpens-deep-learning-s-eye-for-skin-cancer-21f488a4 2026-10-11T14:14:57.838Z daily 0.9 https://www.dermfield.com/articles/florida-s-melanoma-burden-concentrated-in-older-adults-fau-reports-d34d57f9 2026-10-11T13:44:57.828Z daily 0.9 https://www.dermfield.com/articles/medscape-report-examines-adverse-events-from-at-home-microcurrent-devices-070fa263 2026-10-11T12:14:57.773Z daily 0.9 https://www.dermfield.com/articles/jennifer-hsiao-md-on-hidradenitis-suppurativa-treatment-selection-c36c8769 2026-10-11T12:14:57.765Z daily 0.9 https://www.dermfield.com/articles/dna-methylation-rewrites-melanoma-as-it-spreads-study-finds-4c518927 2026-10-11T11:44:57.693Z daily 0.9 https://www.dermfield.com/articles/the-open-access-paradox-of-unfunded-authorship-in-dermatology-e5c178ff 2026-10-11T10:59:57.612Z daily 0.9 https://www.dermfield.com/articles/jaad-publishes-ethics-framework-for-cash-pay-dermatology-3b1e9096 2026-10-11T10:59:57.623Z daily 0.9 https://www.dermfield.com/articles/jaad-examines-dual-financial-interests-in-weight-loss-and-aesthetic-care-e35b1ff5 2026-10-11T10:59:57.623Z daily 0.9 https://www.dermfield.com/articles/visualdx-ceo-flags-decades-old-diagnostic-blind-spot-in-skin-of-color-494d4367 2026-10-11T09:39:57.584Z daily 0.9 https://www.dermfield.com/articles/guselkumab-shows-efficacy-for-inverse-psoriasis-case-report-8880bc2f 2026-10-11T09:39:57.593Z daily 0.9 https://www.dermfield.com/articles/clinicians-push-earlier-jak-inhibitor-use-in-ad-and-vitiligo-45dcc397 2026-10-11T08:09:57.459Z daily 0.9 https://www.dermfield.com/articles/liver-function-test-elevations-rare-with-biologics-in-psoriasis-and-hs-18d77830 2026-10-11T07:39:57.399Z daily 0.9 https://www.dermfield.com/articles/attention-guided-fair-ai-modeling-for-skin-cancer-diagnosis-published-in-nature-e6099aa7 2026-10-11T06:39:57.379Z daily 0.9 https://www.dermfield.com/articles/fda-approves-priteliver-for-refractory-herpes-infections-5550a973 2026-10-11T05:04:57.252Z daily 0.9 https://www.dermfield.com/articles/dunedin-dermatology-access-under-fire-after-rare-cancer-goes-undiagnosed-011a77ad 2026-10-11T03:34:56.476Z daily 0.9 https://www.dermfield.com/articles/mapk-signaling-in-melanoma-from-braf-and-nras-to-combination-therapy-c268c0f1 2026-10-11T01:34:56.305Z daily 0.9 https://www.dermfield.com/articles/clinician-education-named-foundation-of-dermatology-innovation-efd9b7f6 2026-10-11T00:29:56.175Z daily 0.9 https://www.dermfield.com/articles/fall-clinical-2026-first-half-recap-spotlights-psoriasis-and-atopic-dermatitis-d666f1f5 2026-10-11T00:29:56.184Z daily 0.9 https://www.dermfield.com/articles/hydrogel-drug-delivery-for-skin-new-preclinical-review-in-jid-e739ca4b 2026-10-10T14:54:55.441Z daily 0.9 https://www.dermfield.com/articles/wnt-catenin-components-drive-pre-bcc-cell-survival-jid-study-finds-afd9e43e 2026-10-10T14:54:55.435Z daily 0.9 https://www.dermfield.com/articles/new-consensus-statement-defines-remission-disease-activity-in-atopic-dermatitis-efa8e1ba 2026-10-10T14:49:55.434Z daily 0.9 https://www.dermfield.com/articles/hidradenitis-suppurativa-setting-treatment-expectations-before-therapy-starts-4a272549 2026-10-10T14:19:55.384Z daily 0.9 https://www.dermfield.com/articles/the-sunscreen-cancer-myth-and-why-beef-tallow-won-t-shield-you-f5c4d2e0 2026-10-10T13:49:55.321Z daily 0.9 https://www.dermfield.com/articles/machine-learning-maps-environment-and-immunity-in-childhood-eczema-risk-224bb9c4 2026-10-10T13:19:55.384Z daily 0.9 https://www.dermfield.com/articles/nemolizumab-sustains-atopic-dermatitis-control-through-3-years-16eabefa 2026-10-10T13:19:55.396Z daily 0.9 https://www.dermfield.com/articles/glp-1-receptor-agonists-linked-to-onycholysis-in-new-study-7f72a85f 2026-10-10T13:19:55.396Z daily 0.9 https://www.dermfield.com/articles/lab-grown-human-skin-with-vessels-and-immune-cells-reported-b6fdb521 2026-10-10T12:44:55.342Z daily 0.9 https://www.dermfield.com/articles/skinmedica-launches-two-barrier-support-skincare-products-for-summer-16923ed4 2026-10-10T11:19:55.125Z daily 0.9 https://www.dermfield.com/articles/jaad-commentary-examines-siblings-as-caregivers-in-dermatology-2bd231fe 2026-10-10T11:04:55.102Z daily 0.9 https://www.dermfield.com/articles/jaad-publishes-ethics-framework-for-non-physician-delegation-in-mohs-reconstruct-4e324fdf 2026-10-10T11:04:55.102Z daily 0.9 https://www.dermfield.com/articles/jaad-publishes-aad-task-force-guidance-on-2026-ebola-outbreak-e8e7d5a8 2026-10-10T11:04:55.102Z daily 0.9 https://www.dermfield.com/articles/liquid-nitrogen-handling-in-mohs-labs-beyond-convenience-13a2dfd5 2026-10-10T11:04:55.090Z daily 0.9 https://www.dermfield.com/articles/korean-dermatologists-warn-glass-skin-routines-can-damage-the-skin-barrier-bf60ceac 2026-10-10T07:39:54.745Z daily 0.9 https://www.dermfield.com/articles/women-outnumber-men-in-dermatology-yet-lead-its-largest-society-rarely-4961f82d 2026-10-10T06:14:55.051Z daily 0.9 https://www.dermfield.com/articles/bambusa-therapeutics-files-for-ipo-to-fund-eczema-drug-trials-4f072af6 2026-10-10T05:09:54.568Z daily 0.9 https://www.dermfield.com/articles/bambusa-therapeutics-files-for-ipo-to-bankroll-eczema-drug-trials-ff53cb5b 2026-10-10T04:09:54.440Z daily 0.9 https://www.dermfield.com/articles/car-t-immunotherapy-clears-psoriasis-a-92-6-pasi-drop-f7ce9089 2026-10-10T00:29:54.121Z daily 0.9 https://www.dermfield.com/articles/rezolve-aa-trial-reports-durable-hair-regrowth-with-rezpegaldesleukin-ed80b5cd 2026-10-10T00:29:54.130Z daily 0.9 https://www.dermfield.com/articles/real-world-analysis-dupixent-outcomes-consistent-across-skin-tones-c11d092e 2026-10-09T22:39:54.015Z daily 0.9 https://www.dermfield.com/articles/aptos-thread-pro-study-anchors-real-world-aesthetic-outcomes-85680d5f 2026-10-09T22:24:54.027Z daily 0.9 https://www.dermfield.com/articles/lebrikizumab-shows-benefit-in-pediatric-atopic-dermatitis-via-selective-il-13-bl-e4cfffc3 2026-10-09T22:09:54.170Z daily 0.9 https://www.dermfield.com/articles/beyond-acne-personalized-skin-care-through-the-lifespan-9cc3fc55 2026-10-09T22:09:54.171Z daily 0.9 https://www.dermfield.com/articles/alumis-reports-phase-iii-wins-for-oral-psoriasis-pill-analysts-unmoved-6d831608 2026-10-09T22:09:54.171Z daily 0.9 https://www.dermfield.com/articles/chronic-inducible-urticaria-the-quality-of-life-toll-patients-carry-5be3b22f 2026-10-09T22:09:54.171Z daily 0.9 https://www.dermfield.com/articles/erythropoietic-protoporphyria-why-earlier-diagnosis-remains-elusive-a585612f 2026-10-09T22:09:54.145Z daily 0.9 https://www.dermfield.com/articles/roflumilast-0-05-cream-shows-early-ad-clearance-in-infants-c51601f6 2026-10-09T22:09:54.171Z daily 0.9 https://www.dermfield.com/articles/ixekizumabtirzepatide-pair-moves-biomarkers-in-psoriatic-obesity-ebec7985 2026-10-09T22:05:02.451Z daily 0.9 https://www.dermfield.com/articles/psoriasis-and-depression-share-molecular-pathways-review-finds-87128507 2026-10-09T20:19:53.788Z daily 0.9 https://www.dermfield.com/articles/l-oreal-weighs-exit-as-12-000-us-talc-and-hair-relaxer-cases-mount-d51fe0cf 2026-10-09T20:19:53.788Z daily 0.9 https://www.dermfield.com/articles/nea-report-maps-state-level-gaps-in-atopic-dermatitis-care-access-7d1d9a56 2026-10-09T20:19:53.788Z daily 0.9 https://www.dermfield.com/articles/fda-adds-new-warning-to-deoxycholic-acid-label-over-off-label-risks-8a31d8ca 2026-10-09T20:19:53.788Z daily 0.9 https://www.dermfield.com/articles/igfl1-and-igfl4-identified-as-il-4-il-13-driven-amplifiers-in-atopic-dermatitis-7b7919ea 2026-10-09T20:19:53.788Z daily 0.9 https://www.dermfield.com/articles/litifilimab-sustains-skin-clearance-through-52-weeks-in-cutaneous-lupus-644eef28 2026-10-09T20:19:53.750Z daily 0.9 https://www.dermfield.com/articles/icotrokinra-sustains-high-impact-psoriasis-site-clearance-through-2-years-9c1df59d 2026-10-09T20:19:53.788Z daily 0.9 https://www.dermfield.com/articles/pfizer-s-tilrekimig-posts-phase-ii-skin-clearance-sets-up-dupilumab-head-to-head-ca76d752 2026-10-09T20:19:53.788Z daily 0.9 https://www.dermfield.com/articles/jaad-expert-opinion-weighs-hedgehog-inhibitors-in-the-immunotherapy-era-for-adva-9fb36f7c 2026-10-09T20:14:53.707Z daily 0.9 https://www.dermfield.com/articles/jaad-study-defines-new-phenotype-altered-hair-texture-after-alopecia-areata-regr-a23cbf33 2026-10-09T20:14:53.718Z daily 0.9 https://www.dermfield.com/articles/dermatomyositis-therapies-expand-medpage-today-reports-e6496d6d 2026-10-09T20:04:53.768Z daily 0.9 https://www.dermfield.com/articles/fda-approves-8-week-maintenance-dosing-for-ebglyss-in-atopic-dermatitis-3171af3b 2026-10-09T20:04:53.747Z daily 0.9 https://www.dermfield.com/articles/arcutis-presents-zoryve-cream-data-in-infant-atopic-dermatitis-de2dd9d0 2026-10-09T20:04:53.768Z daily 0.9 https://www.dermfield.com/articles/skin-clearance-tops-patient-preferences-for-systemic-psoriasis-therapy-301f0af9 2026-10-09T20:04:53.768Z daily 0.9 https://www.dermfield.com/articles/sun-pharma-commits-2-5m-to-dermatology-professorship-cf57ca43 2026-10-09T20:04:53.768Z daily 0.9 https://www.dermfield.com/articles/phase-2-trial-tests-high-induction-risankizumab-in-plaque-psoriasis-65d9e149 2026-10-09T18:14:54.569Z daily 0.9 https://www.dermfield.com/articles/sanofi-commits-up-to-8b-to-broaden-regeneron-antibody-alliance-567078ed 2026-10-09T18:14:54.569Z daily 0.9 https://www.dermfield.com/articles/skin-cancer-burden-projected-to-surge-through-2050-f8da5532 2026-10-09T18:14:54.569Z daily 0.9 https://www.dermfield.com/articles/amy-s-paller-md-to-step-down-as-chair-of-dermatology-at-northwestern-182d7158 2026-10-09T18:14:54.486Z daily 0.9 https://www.dermfield.com/articles/dermatology-times-publishes-clinician-faq-on-hair-loss-pipeline-7b16453f 2026-10-09T18:14:54.569Z daily 0.9 https://www.dermfield.com/articles/vanderbilt-patient-with-melanoma-receives-til-therapy-e02d21d7 2026-10-09T18:14:54.569Z daily 0.9 https://www.dermfield.com/articles/abbvie-s-zumilokibart-clears-phase-ii-with-long-interval-dosing-signal-5cec6a46 2026-10-09T18:14:54.569Z daily 0.9 https://www.dermfield.com/articles/knight-therapeutics-launches-wynzora-cream-for-psoriasis-in-canada-9c3850d5 2026-10-09T18:14:54.569Z daily 0.9 https://www.dermfield.com/articles/nemluvio-shows-three-year-durability-in-atopic-dermatitis-b742a986 2026-10-09T18:14:54.569Z daily 0.9 https://www.dermfield.com/articles/jaad-article-frames-new-palmoplantar-toxicity-distinct-from-hfs-a92915e4 2026-10-09T18:14:54.569Z daily 0.9 https://www.dermfield.com/articles/ctpa-hosts-first-scientific-conference-in-london-45a5ea72 2026-10-09T18:14:54.569Z daily 0.9 https://www.dermfield.com/articles/melanoma-vaccine-breakthrough-which-cancers-come-next-3cfa8f8a 2026-10-09T18:14:54.569Z daily 0.9 https://www.dermfield.com/articles/dermatology-advisor-examines-clinician-views-on-biosimilar-shift-a99010dd 2026-10-09T18:14:54.569Z daily 0.9 https://www.dermfield.com/articles/how-success-and-remission-are-being-redefined-in-psoriasis-care-68a135cb 2026-10-09T18:14:54.569Z daily 0.9 https://www.dermfield.com/articles/tranquillo-2-ritlecitinib-posts-21-86-f-vasi75-in-vitiligo-05195e0e 2026-10-09T18:14:54.569Z daily 0.9 https://www.dermfield.com/articles/icotrokinra-holds-skin-clearance-at-high-impact-psoriasis-sites-at-2-years-869bd751 2026-10-09T18:14:54.569Z daily 0.9 https://www.dermfield.com/articles/gut-bacteria-predict-skin-cancer-recurrence-study-finds-1363c35f 2026-10-09T18:14:54.569Z daily 0.9 https://www.dermfield.com/articles/late-breaking-eadv-2026-data-back-decisiondx-melanoma-use-in-melanoma-04b3caf5 2026-10-09T18:14:54.569Z daily 0.9 https://www.dermfield.com/articles/pfizer-reports-promising-win-for-experimental-atopic-dermatitis-drug-31695618 2026-10-09T18:15:01.529Z daily 0.9 https://www.dermfield.com/articles/upadacitinib-meets-primary-endpoint-in-jakpppot-ppp-trial-7c648154 2026-10-09T18:14:54.569Z daily 0.9 https://www.dermfield.com/articles/lightweight-multi-scale-cnn-targets-privacy-preserving-skin-cancer-ai-d00ad87d 2026-10-09T18:14:54.569Z daily 0.9 https://www.dermfield.com/articles/oral-minoxidil-for-ctd-alopecia-a-jaad-chart-review-on-cardiovascular-risk-0ecde5cd 2026-10-09T18:04:54.187Z daily 0.9 https://www.dermfield.com/articles/dupilumab-tied-to-lower-atopic-march-risk-vs-corticosteroids-in-kids-3ae13e9f 2026-10-09T17:54:56.219Z daily 0.9 https://www.dermfield.com/articles/roflumilast-0-05-cream-clears-atopic-dermatitis-early-in-infants-92727eed 2026-10-09T17:54:56.230Z daily 0.9 https://www.dermfield.com/articles/medicus-bets-on-melanoma-adc-after-pfizer-deal-62e67693 2026-10-09T16:04:55.371Z daily 0.9 https://www.dermfield.com/articles/apopka-dermatology-practice-drawn-into-wave-of-website-lawsuits-1c82d95c 2026-10-09T16:04:55.371Z daily 0.9 https://www.dermfield.com/articles/lebrikizumab-phase-3-shows-symptom-itch-gains-in-pediatric-ad-38a2eaa3 2026-10-09T16:04:55.371Z daily 0.9 https://www.dermfield.com/articles/il-13amphiregulin-axis-drives-chronic-itch-in-allergic-contact-dermatitis-da91a576 2026-10-09T16:04:55.371Z daily 0.9 https://www.dermfield.com/articles/ai-coupled-with-raman-spectroscopy-improves-skin-cancer-detection-99e4b130 2026-10-09T16:04:55.371Z daily 0.9 https://www.dermfield.com/articles/obsidian-to-present-updated-amsoki-cel-melanoma-data-at-sitc-2026-521587c0 2026-10-09T16:04:55.255Z daily 0.9 https://www.dermfield.com/articles/national-eczema-association-releases-first-national-state-level-ad-report-234e5572 2026-10-09T16:04:55.371Z daily 0.9 https://www.dermfield.com/articles/rhapsido-becomes-first-fda-approved-therapy-for-symptomatic-dermographism-7634ef2d 2026-10-09T16:04:55.371Z daily 0.9 https://www.dermfield.com/articles/eadv-2026-late-stage-readouts-coverage-pending-full-source-e0b0765b 2026-10-09T16:04:55.371Z daily 0.9 https://www.dermfield.com/articles/mexican-team-publishes-posada-based-leprosy-outreach-model-in-jaad-28727a49 2026-10-09T16:04:55.371Z daily 0.9 https://www.dermfield.com/articles/blood-test-flags-melanoma-recurrence-70-5-days-before-clinical-detection-de322bb4 2026-10-09T16:04:55.371Z daily 0.9 https://www.dermfield.com/articles/new-trial-to-test-mrd-guided-escalation-in-advanced-melanoma-68f5a79e 2026-10-09T16:04:55.371Z daily 0.9 https://www.dermfield.com/articles/quality-of-life-tool-for-pediatric-dermatology-passes-validation-a3db4361 2026-10-09T16:04:55.371Z daily 0.9 https://www.dermfield.com/articles/glp-1-users-report-onycholysis-at-four-times-the-rate-of-nonusers-8abefb49 2026-10-09T16:04:55.371Z daily 0.9 https://www.dermfield.com/articles/free-resident-run-dermatology-clinic-maps-care-gaps-in-uninsured-urban-patients-72a3eccb 2026-10-09T16:04:55.371Z daily 0.9 https://www.dermfield.com/articles/fda-expands-urticaria-drug-indication-to-symptomatic-dermographism-1bfdeff8 2026-10-09T16:04:55.371Z daily 0.9 https://www.dermfield.com/articles/fda-approves-light-based-therapy-for-a-common-skin-cancer-97b9027e 2026-10-09T16:04:55.371Z daily 0.9 https://www.dermfield.com/articles/89-of-psoriasis-patients-on-j-j-pill-report-clear-genital-skin-at-two-years-a2192e5c 2026-10-09T16:04:55.371Z daily 0.9 https://www.dermfield.com/articles/new-framework-proposes-open-state-principle-for-aesthetic-outcomes-e818d46b 2026-10-09T16:04:55.371Z daily 0.9 https://www.dermfield.com/articles/first-patient-treated-in-trial-targeting-immunotherapy-resistance-c54585ab 2026-10-09T16:04:55.371Z daily 0.9 https://www.dermfield.com/articles/eadv-2026-late-breakers-back-decisiondx-melanoma-for-slnb-triage-9b946daf 2026-10-09T16:04:55.371Z daily 0.9 https://www.dermfield.com/articles/the-observer-editorial-demands-social-media-stop-promoting-sunbeds-efb6b8ff 2026-10-09T16:04:55.371Z daily 0.9 https://www.dermfield.com/articles/first-world-chronic-hand-eczema-day-set-for-october-5-59be32d5 2026-10-09T16:04:55.371Z daily 0.9 https://www.dermfield.com/articles/tulisokibart-posts-first-positive-phase-ii-anti-tl1a-read-out-e8e89290 2026-10-09T16:04:55.371Z daily 0.9 https://www.dermfield.com/articles/ai-raman-spectroscopy-pairing-sharpens-skin-cancer-detection-c06fab6c 2026-10-09T16:04:55.371Z daily 0.9 https://www.dermfield.com/articles/mrd-guided-melanoma-trial-enrolls-first-patients-with-signatera-f37f0d23 2026-10-09T16:04:55.371Z daily 0.9 https://www.dermfield.com/articles/atopic-dermatitis-linked-to-lower-height-in-children-645d93bd 2026-10-09T16:04:55.371Z daily 0.9 https://www.dermfield.com/articles/global-study-ranks-best-therapies-for-cutaneous-t-cell-lymphoma-ce49cba3 2026-10-09T16:04:55.371Z daily 0.9 https://www.dermfield.com/articles/ai-cuts-skin-cancer-waiting-times-in-bradford-3c5a5fbb 2026-10-09T16:04:55.371Z daily 0.9 https://www.dermfield.com/articles/epicutis-names-james-y-wang-md-mba-chief-medical-officer-cabd229f 2026-10-09T16:04:55.371Z daily 0.9 https://www.dermfield.com/articles/azitra-develops-functional-human-filaggrin-for-skin-barrier-support-272914f4 2026-10-09T16:04:55.371Z daily 0.9 https://www.dermfield.com/articles/icotrokinra-sustains-high-impact-site-clearance-at-2-years-ccba48ce 2026-10-09T16:04:55.371Z daily 0.9 https://www.dermfield.com/articles/eadv-2026-presenters-link-climate-shifts-to-skin-disease-burden-e153743e 2026-10-09T16:04:55.371Z daily 0.9 https://www.dermfield.com/articles/skin-microbiome-research-maps-new-links-to-cutaneous-aging-71a326b5 2026-10-09T16:04:55.371Z daily 0.9 https://www.dermfield.com/articles/chronic-toxicity-after-adjuvant-anti-pd-1-in-melanoma-under-scrutiny-3de28217 2026-10-09T16:04:55.371Z daily 0.9 https://www.dermfield.com/articles/gut-skin-axis-research-ties-microbial-metabolites-to-atopic-dermatitis-immunity-af71a92c 2026-10-09T16:04:55.371Z daily 0.9 https://www.dermfield.com/articles/upadacitinib-beats-nemolizumab-on-easi-75-and-itch-in-indirect-ad-analysis-8ebae911 2026-10-09T16:04:55.371Z daily 0.9 https://www.dermfield.com/articles/new-study-points-to-possible-biological-link-between-glp-1-drugs-and-hair-loss-i-e7af2544 2026-10-09T16:04:55.371Z daily 0.9 https://www.dermfield.com/articles/global-consensus-aims-to-standardize-integrated-skin-care-for-aesthetic-results-48f3eb88 2026-10-09T16:04:55.371Z daily 0.9 https://www.dermfield.com/articles/foundation-models-usher-in-a-new-ai-era-for-dermatology-6cee5242 2026-10-09T16:04:55.371Z daily 0.9 https://www.dermfield.com/articles/two-thirds-of-appalachian-counties-lack-a-dermatologist-registry-finds-05d33585 2026-10-09T16:04:55.371Z daily 0.9 https://www.dermfield.com/articles/egg-tops-food-allergen-sensitization-in-iranian-infants-with-eczema-59883504 2026-10-09T16:04:55.371Z daily 0.9 https://www.dermfield.com/articles/sun-pharma-funds-2-5-million-dermatology-professorship-at-mount-sinai-8b3a2b4a 2026-10-09T16:04:55.371Z daily 0.9 https://www.dermfield.com/articles/nhs-deploys-ai-for-skin-cancer-checks-across-sussex-8c6aad80 2026-10-09T16:04:55.371Z daily 0.9 https://www.dermfield.com/articles/ido1-inhibitor-fails-to-amplify-t-cell-response-to-melanoma-vaccine-219cafb7 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/vessel-patterns-under-the-microscope-flag-deadly-sebaceous-skin-tumors-fae8fc51 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/glp-1-drugs-and-psoriasis-what-the-evidence-actually-shows-cd7d4e0f 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/nektar-reports-durable-hair-regrowth-with-rezpeg-phase-iii-alopecia-trial-next-7777df2c 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/novo-nordisk-ceo-targets-longevity-and-aesthetics-beyond-weight-loss-3eed7592 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/fda-approves-rha-redensity-eye-for-infraorbital-hollowing-bcbe79b7 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/study-viral-glass-skin-tiktoks-carry-misleading-skincare-claims-0ec9fda8 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/oturkibart-posts-74-5-itch-response-in-phase-3-prurigo-nodularis-trial-63ec2a10 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/leo-pharma-brings-delgocitinib-cream-data-to-eadv-2026-0209427c 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/42-6-of-countries-flag-climate-linked-skin-disease-shifts-a19a2ac5 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/nemolizumab-sustains-atopic-dermatitis-response-at-3-years-4b0eeb5d 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/cureus-paper-tracks-patient-reported-outcomes-after-aptos-thread-procedures-5a2a104a 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/omalizumab-drug-survival-reaches-3-1-years-in-chronic-urticaria-ca956e73 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/dapsone-induced-methemoglobinemia-dermatology-s-outpatient-warning-signs-6e41a86d 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/blocking-cellular-recycling-cuts-psoriasis-inflammation-723e14e2 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/ema-backs-first-oral-il-23-receptor-agent-for-plaque-psoriasis-3ffa53aa 2026-10-09T15:59:59.766Z daily 0.9 https://www.dermfield.com/articles/il-17-signaling-links-psoriasis-to-cardiometabolic-risk-review-finds-3b21f513 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/researchers-propose-federated-validation-for-melanoma-biomarker-e2fb2c1e 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/imaging-mass-cytometry-maps-cscc-immune-heterogeneity-in-transplants-870ad73b 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/dupilumab-tied-to-more-oral-food-challenge-reactions-986e7e2a 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/glp-1-use-linked-to-fourfold-higher-rate-of-nail-detachment-ef999c9e 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/upadacitinib-sustains-repigmentation-at-week-76-in-non-segmental-vitiligo-6e310b49 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/pfizer-details-phase-ii-data-for-dupixent-challenger-in-atopic-dermatitis-e2d4dffc 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/tulisokibart-posts-efficacy-in-phase-2b-for-moderate-to-severe-hs-e1e6a041 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/study-probes-genetic-link-between-glp-1-drugs-and-male-pattern-hair-loss-5f5714b9 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/ucla-health-spotlights-dermatologist-s-skin-aging-inquiry-26405c60 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/sofwave-gains-nmpa-approval-to-enter-mainland-china-aesthetics-market-9b958812 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/generalized-pustular-psoriasis-prevalence-rises-56-over-15-years-448d6c9d 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/merck-s-tulisokibart-hits-primary-endpoint-in-phase-ii-tl1a-trial-48f9b495 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/national-eczema-association-releases-first-national-and-state-level-ad-report-7cf94d83 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/vascularized-human-skin-assembloids-model-skin-organization-in-vitro-54543d10 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/weak-sunlight-can-still-damage-dna-scientists-warn-6f5d1045 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/eli-lilly-reports-positive-phase-3b-results-for-ebglyss-f24dbdaa 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/sanofi-signs-new-8-billion-pact-with-regeneron-9ef6cf86 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/bimekizumab-rescues-palmoplantar-psoriasis-after-brodalumab-failure-b443b5f2 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/bemotrizinol-in-pediatric-sunscreen-what-dermatology-times-reports-f348f0b0 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/organon-to-present-real-world-vtama-data-at-2026-fall-clinical-70645224 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/rezpegaldesleukin-biomarker-data-take-late-breaking-slot-at-eadv-2026-0ac3eb8a 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/enpatoran-phase-2-trial-reports-symptom-improvement-in-cutaneous-lupus-39b9fef0 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/risankizumab-tops-ustekinumab-on-complete-clearance-in-pediatric-psoriasis-6c21111d 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/leo-pharma-brings-tralokinumab-real-world-ad-data-to-eadv-2026-423aabf8 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/bambusa-initiates-subcutaneous-bbt001-dosing-in-atopic-dermatitis-00078f72 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/abolis-launches-mine-platform-for-microbial-cosmetic-ingredient-discovery-3e568813 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/eadv-2026-late-breaker-decisiondx-melanoma-data-back-slnb-and-post-surgical-use-fa8eee88 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/rezpegaldesleukin-long-term-data-unveiled-at-eadv-2026-d57c07e8 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/rezolve-aa-trial-reports-durable-hair-regrowth-with-rezpegaldesleukin-8be5d42d 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/tulisokibart-hits-primary-endpoint-in-phase-2b-hs-trial-076f51b1 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/upadacitinib-shows-feasibility-in-palmoplantar-pustulosis-751bd37e 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/prospective-study-maps-infantile-dermatoses-in-rural-north-india-0dc231b3 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/denifanstat-sustains-acne-lesion-reductions-through-52-weeks-91ab7998 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/psoriasis-belongs-in-the-reproductive-health-conversation-79d320e8 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/perturbfate-maps-how-melanoma-cells-converge-on-vemurafenib-resistance-51666a1d 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/frontiers-backs-component-resolved-testing-for-atopic-dermatitis-7a45aa67 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/earlier-bimekizumab-use-lifts-3-year-hs-clearance-in-be-heard-ext-72253736 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/real-world-data-back-avelumab-in-merkel-cell-carcinoma-9244bc31 2026-10-09T16:00:04.160Z daily 0.9 https://www.dermfield.com/articles/skin-bone-marrow-axis-identified-as-new-therapeutic-target-in-psoriasis-ff17f3aa 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/tulisokibart-hits-hiscr50-endpoint-in-phase-2b-hidradenitis-suppurativa-trial-f4f4b242 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/sanofi-regeneron-expand-antibody-pact-to-four-il-13-il-4-candidates-5d47be0e 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/tudriqev-is-now-available-in-the-u-s-for-advanced-melanoma-2768803b 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/pfizer-s-tilrekimig-posts-phase-2-skin-clearance-signal-in-ad-fb4a3fe3 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/sanofi-commits-1b-to-broaden-regeneron-alliance-build-next-gen-dupixent-00eea9f2 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/ascletis-reports-positive-28-day-u-s-proof-of-concept-results-for-oral-il-17a-in-cfc5cbd7 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/pfizer-s-trispecific-antibody-tilrekimig-hits-easi-75-in-phase-2-ad-608743c9 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/major-review-maps-persistent-care-gap-for-melanoma-survivors-9804e346 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/autonomous-ai-could-free-capacity-for-8-500-plus-dermatology-visits-e33cd545 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/leo-pharma-brings-tralokinumab-real-world-ad-data-to-eadv-2026-c8e6f800 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/plasma-ev-mir-148a-3p-tied-to-plasmablast-surge-in-bullous-pemphigoid-744ae64d 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/rezpegaldesleukin-long-term-data-to-feature-at-eadv-2026-15ef4031 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/ebglyss-hit-53-clearance-in-hand-and-foot-eczema-vs-27-on-placebo-9745dc62 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/tareen-dermatology-sets-sept-15-opening-for-grand-forks-clinic-4cacb1fe 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/dermdx-case-pink-papules-around-the-mouth-fa09e977 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/ucb-s-galvokimig-advances-in-atopic-dermatitis-pipeline-cb758b85 2026-10-09T15:59:59.964Z daily 0.9 https://www.dermfield.com/articles/two-hedgehog-inhibitors-one-pathway-telling-vismodegib-and-sonidegib-apart-in-bc-b1eb349e 2026-10-09T15:55:11.558Z daily 0.9 https://www.dermfield.com/articles/tempo-therapeutics-wins-2-25m-nih-grant-for-map-wound-healing-469ae693 2026-10-09T15:55:11.558Z daily 0.9 https://www.dermfield.com/articles/personalised-mrna-vaccine-stops-melanoma-returning-in-reported-breakthrough-93a32014 2026-10-09T15:55:11.558Z daily 0.9 https://www.dermfield.com/articles/boise-dermatology-clinic-probes-how-patient-records-reached-a-dumpster-7aef345f 2026-10-09T15:55:11.558Z daily 0.9 https://www.dermfield.com/articles/journal-digest-oral-minoxidil-consensus-jak-imaging-rf-microneedling-for-rosacea-4f20512a 2026-10-09T15:55:11.558Z daily 0.9 https://www.dermfield.com/articles/three-ion-channel-compounds-show-scar-reduction-promise-in-mouse-model-457bcdc8 2026-10-09T15:55:11.558Z daily 0.9 https://www.dermfield.com/articles/real-world-data-support-long-term-dupilumab-use-in-pediatric-atopic-dermatitis-c2a1da6b 2026-10-09T15:55:20.113Z daily 0.9 https://www.dermfield.com/articles/technology-enabled-skin-cancer-screening-may-improve-care-for-hct-recipients-49e611c3 2026-10-09T15:55:11.558Z daily 0.9 https://www.dermfield.com/articles/nature-publishes-multimodal-ai-model-for-skin-cancer-classification-818070dd 2026-10-09T15:55:11.558Z daily 0.9 https://www.dermfield.com/articles/uk-records-highest-ever-count-of-high-risk-skin-cancers-bc25e2ac 2026-10-09T15:55:11.558Z daily 0.9 https://www.dermfield.com/articles/gut-microbes-emerge-as-unexpected-players-in-eczema-research-fbbc1705 2026-10-09T15:55:11.558Z daily 0.9 https://www.dermfield.com/articles/primary-penile-melanoma-cureus-reports-a-rare-malignancy-52671175 2026-10-09T15:55:11.851Z daily 0.9 https://www.dermfield.com/articles/sequencing-hedgehog-inhibitors-with-surgery-radiation-and-immunotherapy-in-bcc-9c5289a7 2026-10-09T15:55:11.558Z daily 0.9 https://www.dermfield.com/articles/jid-perspective-ties-climate-change-to-global-skin-disease-burden-422482d3 2026-10-09T15:55:11.558Z daily 0.9 https://www.dermfield.com/articles/melvin-chiu-named-chair-of-dermatology-at-keck-school-of-medicine-159b318a 2026-10-09T15:55:11.558Z daily 0.9 https://www.dermfield.com/articles/skin-microbiota-can-be-engineered-into-topical-vaccines-93e0d6b4 2026-10-09T15:55:11.558Z daily 0.9 https://www.dermfield.com/articles/tildrakizumab-delivers-long-term-control-in-hard-to-treat-psoriasis-areas-b5c48b2e 2026-10-09T15:55:11.558Z daily 0.9 https://www.dermfield.com/articles/uk-melanoma-cases-hit-record-level-analysis-finds-b791a7ac 2026-10-09T15:55:11.558Z daily 0.9 https://www.dermfield.com/articles/immune-cell-dysfunction-not-absence-marks-skin-cancer-risk-584a4106 2026-10-09T15:55:11.558Z daily 0.9 https://www.dermfield.com/articles/uc-davis-health-opens-new-dermatology-clinic-to-expand-patient-access-b62a8806 2026-10-09T15:55:11.558Z daily 0.9 https://www.dermfield.com/articles/natera-launches-randomized-signatera-guided-interventional-melanoma-study-7cf0d2cd 2026-10-09T15:55:11.558Z daily 0.9 https://www.dermfield.com/articles/hypergraph-ai-model-targets-skin-cancer-detection-in-nature-paper-4f13895a 2026-10-09T15:55:11.558Z daily 0.9 https://www.dermfield.com/articles/eadv-2026-to-feature-hs-assessment-and-follow-up-training-for-nps-and-pas-917083c2 2026-10-09T15:55:11.558Z daily 0.9 https://www.dermfield.com/articles/low-power-laser-plus-nanoparticles-removes-melanoma-tumors-d05c64c6 2026-10-09T15:55:11.558Z daily 0.9 https://www.dermfield.com/articles/glp-1-drug-makes-its-case-for-treating-plaque-psoriasis-66f8f628 2026-10-09T15:55:11.558Z daily 0.9 https://www.dermfield.com/articles/new-delhi-to-host-1-250-global-aesthetic-medicine-experts-at-coscon-2026-f35d3785 2026-10-09T15:55:11.558Z daily 0.9 https://www.dermfield.com/articles/melatonin-may-offer-a-surprising-shield-against-skin-cancer-review-suggests-38cd300e 2026-10-09T15:55:11.558Z daily 0.9 https://www.dermfield.com/articles/dermatology-and-plastic-surgery-drive-74-of-foreign-patient-visits-in-korea-a72eef42 2026-10-09T15:55:11.558Z daily 0.9 https://www.dermfield.com/articles/orka-stock-falls-5-despite-positive-week-28-psoriasis-efficacy-data-ab9925b2 2026-10-09T15:55:12.049Z daily 0.9 https://www.dermfield.com/articles/up-to-14-of-patch-tested-patients-react-to-gold-but-it-rarely-matters-d5a7dfab 2026-10-09T15:55:11.558Z daily 0.9 https://www.dermfield.com/articles/sun-pharma-funds-endowed-dermatology-professorship-at-mount-sinai-94a453cb 2026-10-09T15:55:11.558Z daily 0.9 https://www.dermfield.com/articles/dietary-supplements-aid-psoriasis-care-but-effect-estimates-vary-a904a283 2026-10-09T15:55:11.558Z daily 0.9 https://www.dermfield.com/articles/northwestern-radiotherapy-reshapes-immune-response-in-skin-cancer-a93cb214 2026-10-09T15:55:11.558Z daily 0.9 https://www.dermfield.com/articles/conditional-gan-cnn-vit-pipeline-targets-skin-cancer-minority-classes-fd982a34 2026-10-09T15:55:11.558Z daily 0.9 https://www.dermfield.com/articles/algorithms-cannot-heal-rural-dermatology-s-workforce-gap-medscape-argues-178a461b 2026-10-09T15:55:11.558Z daily 0.9 https://www.dermfield.com/articles/tareen-family-commits-5-million-to-found-und-dermatology-department-6f059ad6 2026-10-09T15:55:11.558Z daily 0.9 https://www.dermfield.com/articles/skin-of-color-textbooks-face-scrutiny-over-image-representation-15364fdf 2026-10-09T15:55:11.430Z daily 0.9 https://www.dermfield.com/articles/acral-melanoma-study-in-nature-links-ancestry-to-origin-prognosis-d8a50696 2026-10-09T15:55:11.558Z daily 0.9 https://www.dermfield.com/articles/dartmouth-hitchcock-announces-first-dermatology-clinic-for-down-syndrome-0a311e7b 2026-10-09T15:55:11.558Z daily 0.9 https://www.dermfield.com/articles/fda-approves-therapy-medpage-calls-a-potential-game-changer-for-psoriasis-b0d7e52a 2026-10-09T15:55:11.558Z daily 0.9 https://www.dermfield.com/articles/albinism-awareness-month-puts-skin-cancer-risk-back-in-focus-5f643cc3 2026-10-09T15:55:14.577Z daily 0.9 https://www.dermfield.com/articles/tanning-beds-triple-melanoma-risk-study-warns-11cc1ca8 2026-10-09T15:55:11.558Z daily 0.9 https://www.dermfield.com/articles/uc-san-diego-health-first-hospital-to-deploy-civaderm-radioactive-bandage-for-sk-87e7aff1 2026-10-09T15:55:11.558Z daily 0.9 https://www.dermfield.com/articles/secukinumab-clears-plaque-psoriasis-in-peritoneal-dialysis-patient-case-report-b20d8569 2026-10-09T15:55:11.558Z daily 0.9 https://www.dermfield.com/articles/nhs-south-east-deploys-ai-skin-cancer-checks-at-record-scale-4bf5dbef 2026-10-08T14:46:51.438Z daily 0.9 https://www.dermfield.com/articles/the-closer-look-project-aims-to-improve-skin-cancer-detection-9b9fb3f9 2026-10-08T14:46:45.534Z daily 0.9 https://www.dermfield.com/articles/two-center-study-examines-scars-with-overlapping-features-3127bd2b 2026-10-08T14:00:50.183Z daily 0.9 https://www.dermfield.com/articles/jaad-publishes-the-lesion-the-patient-apologizes-for-2a57e9c2 2026-10-08T14:00:50.183Z daily 0.9 https://www.dermfield.com/articles/jaad-study-examines-pediatric-enrollment-in-alopecia-areata-trials-01680419 2026-10-08T14:00:50.161Z daily 0.9 https://www.dermfield.com/articles/necrotic-eruptions-flag-severe-ici-associated-myositis-in-jaad-report-e6d56081 2026-10-08T14:00:50.183Z daily 0.9 https://www.dermfield.com/articles/older-americans-face-steep-travel-times-to-reach-dermatologists-c92deeac 2026-10-08T13:56:04.529Z daily 0.9 https://www.dermfield.com/articles/olehenriksen-opens-scandiland-pop-up-in-new-york-for-lip-launch-20377ffd 2026-10-08T11:40:49.191Z daily 0.9 https://www.dermfield.com/articles/michela-rossini-wins-pezcoller-sic-scholarship-for-melanoma-research-f554e931 2026-10-08T09:20:43.351Z daily 0.9 https://www.dermfield.com/articles/pediatric-atopic-dermatitis-linked-to-higher-ibd-risk-in-meta-analysis-9631665a 2026-10-08T08:20:18.827Z daily 0.9 https://www.dermfield.com/articles/new-guidance-maps-cosmetic-dermatology-safety-in-pregnancy-0b32836e 2026-10-08T07:50:18.789Z daily 0.9 https://www.dermfield.com/articles/nemluvio-shows-durable-three-year-responses-in-atopic-dermatitis-431ef5d3 2026-10-08T05:45:18.322Z daily 0.9 https://www.dermfield.com/articles/galderma-presents-new-nemluvio-data-in-atopic-dermatitis-aged-12-a68a05b2 2026-10-08T05:45:18.291Z daily 0.9 https://www.dermfield.com/articles/fda-approves-remibrutinib-for-symptomatic-dermographism-8014ba96 2026-10-08T04:45:18.472Z daily 0.9 https://www.dermfield.com/articles/upadacitinib-clears-refractory-arpc-after-dupilumab-failure-b3f2acbd 2026-10-08T02:15:17.667Z daily 0.9 https://www.dermfield.com/articles/upadacitinib-shows-long-term-utility-across-three-immune-skin-diseases-b9479ebc 2026-10-08T02:15:17.698Z daily 0.9 https://www.dermfield.com/articles/dupilumab-reshapes-skin-microbiome-in-netherton-disease-f4403596 2026-10-08T01:45:17.477Z daily 0.9 https://www.dermfield.com/articles/nhs-england-south-east-deploys-largest-autonomous-medical-ai-in-nhs-history-9966c090 2026-10-08T00:45:17.318Z daily 0.9 https://www.dermfield.com/articles/korea-audit-1-54m-foreign-derm-plastic-surgery-patients-c83d2420 2026-10-08T00:45:17.336Z daily 0.9 https://www.dermfield.com/articles/nhs-south-east-deploys-skin-analytics-ai-for-skin-cancer-checks-7e097a61 2026-10-08T00:10:17.347Z daily 0.9 https://www.dermfield.com/articles/nhs-england-south-east-deploys-skin-analytics-ai-for-skin-cancer-checks-f0b46d68 2026-10-07T23:40:17.274Z daily 0.9 https://www.dermfield.com/articles/hugel-sets-1-trillion-won-sales-target-within-three-years-411b0bd3 2026-10-07T23:40:17.233Z daily 0.9 https://www.dermfield.com/articles/nhs-england-south-east-deploys-skin-analytics-ai-for-skin-cancer-checks-64f00eeb 2026-10-07T23:10:17.040Z daily 0.9 https://www.dermfield.com/articles/selective-oral-jak-tek-inhibitor-succeeds-in-phase-3-vitiligo-trial-0b56c064 2026-10-07T23:10:17.059Z daily 0.9 https://www.dermfield.com/articles/hair-growth-supplements-dermatologists-say-the-ingredient-decides-b208b034 2026-10-07T23:10:17.059Z daily 0.9 https://www.dermfield.com/articles/imiquimod-plus-cryotherapy-beats-phototherapy-for-skin-cancer-precursor-53562cbe 2026-10-07T22:40:17.173Z daily 0.9 https://www.dermfield.com/articles/psoriasis-treatment-selection-should-start-beyond-the-skin-friedman-says-01e939f0 2026-10-03T10:20:10.302Z daily 0.9 https://www.dermfield.com/articles/early-ivarmacitinib-response-predicts-durable-ad-outcomes-0af2636a 2026-10-03T09:15:10.060Z daily 0.9 https://www.dermfield.com/articles/daxdilimab-cuts-disease-activity-in-moderate-to-severe-discoid-lupus-3af9a386 2026-10-03T06:15:09.474Z daily 0.9 https://www.dermfield.com/articles/ai-in-dermatology-rapid-adoption-meets-integration-reality-17734c97 2026-10-03T01:10:08.576Z daily 0.9 https://www.dermfield.com/articles/digital-skincare-marketing-shapes-acne-self-experimentation-and-adherence-f0b083db 2026-10-03T00:40:09.690Z daily 0.9 https://www.dermfield.com/articles/nektar-reports-early-onset-of-improvement-with-rezpegaldesleukin-in-atopic-derma-45f5abbd 2026-10-02T23:35:08.534Z daily 0.9 https://www.dermfield.com/articles/obsidian-to-present-melanoma-therapy-data-at-november-conference-1748b1c0 2026-10-02T19:35:07.866Z daily 0.9 https://www.dermfield.com/articles/pfizer-trispecific-antibody-hits-skin-clearance-endpoint-in-phase-2-ad-trial-b904ddd3 2026-10-02T16:30:09.136Z daily 0.9 https://www.dermfield.com/articles/pfizer-eczema-drug-posts-61-response-as-florida-sues-e45835c4 2026-10-02T16:30:09.115Z daily 0.9 https://www.dermfield.com/articles/evo301-a-long-acting-candidate-shows-early-promise-in-atopic-dermatitis-d7014a84 2026-10-02T16:30:09.136Z daily 0.9 https://www.dermfield.com/articles/epidermal-tlr4-deletion-shields-mouse-skin-from-uv-damage-and-tumors-9065c4c8 2026-10-02T15:45:09.008Z daily 0.9 https://www.dermfield.com/articles/basf-unveils-collagen-hybridizing-peptide-platform-at-ifscc-2026-815be1c9 2026-10-02T15:35:10.481Z daily 0.9 https://www.dermfield.com/articles/lilly-signals-entry-into-aesthetics-market-1eac7df3 2026-10-02T15:30:07.226Z daily 0.9 https://www.dermfield.com/articles/pfizer-eczema-drug-clears-skin-in-mid-stage-trial-1bf67573 2026-10-02T15:00:08.190Z daily 0.9 https://www.dermfield.com/articles/dupilumab-pregnancy-registry-shows-no-birth-defect-signal-1a5c936a 2026-10-02T15:00:08.117Z daily 0.9 https://www.dermfield.com/articles/civatech-s-civaderm-reaches-first-commercial-use-in-skin-cancer-d79820a7 2026-10-02T14:50:07.185Z daily 0.9 https://www.dermfield.com/articles/hydrochlorothiazide-use-linked-to-elevated-skin-cancer-risk-c72f7057 2026-10-02T14:50:07.204Z daily 0.9 https://www.dermfield.com/articles/evaxion-to-present-new-evx-01-immune-data-at-sitc-2026-4e1442c7 2026-10-02T14:30:09.532Z daily 0.9 https://www.dermfield.com/articles/grey-hair-may-be-a-byproduct-of-anti-cancer-stem-cell-defense-6a3fba7a 2026-10-02T14:30:09.516Z daily 0.9 https://www.dermfield.com/articles/aulos-bioscience-to-present-phase-1-2-imneskibart-data-at-sitc-2026-513d9dc3 2026-10-02T14:25:06.877Z daily 0.9 https://www.dermfield.com/articles/obsidian-to-present-updated-amsoki-cel-phase-1-2-melanoma-data-at-sitc-2026-c1b7a44d 2026-10-02T13:25:20.734Z daily 0.9 https://www.dermfield.com/articles/obsidian-to-present-melanoma-therapy-data-at-november-conference-f88717fd 2026-10-02T13:25:14.524Z daily 0.9 https://www.dermfield.com/articles/biomerenew-s-dr-ashley-naidoo-on-the-skin-microbiome-and-skincare-5229d82a 2026-10-02T12:30:08.386Z daily 0.9 https://www.dermfield.com/articles/zasocitinib-beats-deucravacitinib-on-skin-clearance-in-phase-3-0e9595eb 2026-10-02T12:30:08.403Z daily 0.9 https://www.dermfield.com/articles/nemluvio-delivers-sustained-improvement-in-moderate-to-severe-atopic-dermatitis-46201e9a 2026-10-02T12:25:06.430Z daily 0.9 https://www.dermfield.com/articles/amorepacific-backs-junevity-to-build-gene-network-skin-longevity-cosmetics-614c5f68 2026-10-02T11:30:06.811Z daily 0.9 https://www.dermfield.com/articles/haus-labs-expands-bronzer-range-from-six-to-11-shades-after-backlash-6b2c4368 2026-10-02T11:10:06.556Z daily 0.9 https://www.dermfield.com/articles/inside-an-mrna-melanoma-vaccine-trial-a-patient-s-view-258d500a 2026-10-02T10:55:06.562Z daily 0.9 https://www.dermfield.com/articles/j-j-reports-two-year-icotrokinra-durability-data-in-plaque-psoriasis-cc0dafe4 2026-10-02T10:25:06.159Z daily 0.9 https://www.dermfield.com/articles/climate-change-linked-to-worsening-skin-disease-in-42-of-countries-fd53b1ec 2026-10-02T10:25:06.168Z daily 0.9 https://www.dermfield.com/articles/ruxolitinib-clears-steroid-refractory-sweet-syndrome-in-pv-case-f26706d3 2026-10-02T10:15:09.932Z daily 0.9 https://www.dermfield.com/articles/merck-reports-first-positive-phase-3-for-personalized-mrna-melanoma-therapy-098e3e22 2026-10-02T09:25:06.187Z daily 0.9 https://www.dermfield.com/articles/lebrikizumab-sustains-itch-and-lesion-improvements-for-five-years-in-moderate-to-fc5f8739 2026-10-02T04:50:07.216Z daily 0.9 https://www.dermfield.com/articles/autonomous-ai-eyes-skin-cancer-risk-stratification-role-4a81afe9 2026-10-02T04:40:05.175Z daily 0.9 https://www.dermfield.com/articles/psoriasis-care-redefined-clear-skin-is-no-longer-the-sole-endpoint-7cd7fa66 2026-10-02T04:20:04.787Z daily 0.9 https://www.dermfield.com/articles/low-intensity-uv-damages-skin-dna-even-without-visible-erythema-fecfa85c 2026-10-02T04:10:05.439Z daily 0.9 https://www.dermfield.com/articles/lebrikizumab-shows-rapid-gains-in-hand-and-foot-atopic-dermatitis-9714a1fe 2026-10-02T03:50:05.502Z daily 0.9 https://www.dermfield.com/articles/intralesional-bo-112-surfaces-as-nonsurgical-option-for-high-risk-bcc-01ed0152 2026-10-02T03:40:04.480Z daily 0.9 https://www.dermfield.com/articles/atopic-dermatitis-or-subacute-cutaneous-lupus-a-clinicopathologic-puzzle-20b97fb2 2026-10-02T03:15:03.245Z daily 0.9 https://www.dermfield.com/articles/3d-facial-reconstruction-powers-privacy-preserving-ai-skin-analysis-78f04aa3 2026-10-02T02:55:04.614Z daily 0.9 https://www.dermfield.com/articles/immunocore-completes-540-patient-enrollment-in-phase-3-tebe-am-melanoma-trial-c52d1034 2026-10-02T02:45:03.333Z daily 0.9 https://www.dermfield.com/articles/silgan-debuts-melodie-pirouette-sni-13-pump-for-refillable-molded-glass-07d9da41 2026-10-02T02:40:03.028Z daily 0.9 https://www.dermfield.com/articles/inmc-reports-updated-five-year-survival-data-for-neoadjuvant-melanoma-therapy-547a3d70 2026-10-02T01:45:01.568Z daily 0.9 https://www.dermfield.com/articles/plaintiff-attorneys-vie-for-leadership-roles-in-dupixent-mdl-over-cancer-claims-6e5ae6f2 2026-10-02T01:15:01.515Z daily 0.9 https://www.dermfield.com/articles/intralesional-bo-112-emerges-as-nonsurgical-option-for-high-risk-bcc-88ecdc80 2026-10-02T01:15:01.488Z daily 0.9 https://www.dermfield.com/articles/sanofi-and-regeneron-re-up-alliance-as-dupixent-patent-cliff-nears-c64ea0fa 2026-10-02T00:45:01.335Z daily 0.9 https://www.dermfield.com/articles/abrocitinib-alters-skin-microbiome-in-atopic-dermatitis-9227d3e9 2026-10-01T22:12:22.518Z daily 0.9 https://www.dermfield.com/articles/replimune-launches-its-melanoma-therapy-in-the-u-s-market-7389e928 2026-10-01T22:12:22.518Z daily 0.9 https://www.dermfield.com/articles/serum-proteomics-ties-distinct-signatures-to-atopic-dermatitis-severity-956d2314 2026-10-01T22:12:22.502Z daily 0.9 https://www.dermfield.com/articles/upadacitinib-sustains-vitiligo-repigmentation-to-76-weeks-2f6e64ad 2026-10-01T21:37:22.515Z daily 0.9 https://www.dermfield.com/articles/nih-fellowship-funds-wayne-state-student-s-melanoma-immunotherapy-work-c7f9ffb3 2026-10-01T21:12:22.416Z daily 0.9 https://www.dermfield.com/articles/pfizer-reports-tilrekimig-phase-2-atopic-dermatitis-results-4568ee9e 2026-10-01T19:12:22.273Z daily 0.9 https://www.dermfield.com/articles/highlight-therapeutics-reports-positive-phase-2b-data-for-intralesional-bo-112-i-b63cb205 2026-10-01T19:12:22.288Z daily 0.9 https://www.dermfield.com/articles/pfizer-reports-significant-skin-clearance-with-eczema-drug-36db31ad 2026-10-01T19:12:22.288Z daily 0.9 https://www.dermfield.com/articles/simone-biles-fronts-arcutis-skin-to-believe-campaign-3990d5d5 2026-10-01T16:07:22.017Z daily 0.9 https://www.dermfield.com/articles/bambusa-moves-bbt001-into-subcutaneous-dosing-in-atopic-dermatitis-ae01ac6d 2026-10-01T15:23:08.824Z daily 0.9 https://www.dermfield.com/articles/lutris-pharma-reports-durable-phase-2-benefit-for-lut014-gel-in-egfr-inhibitor-r-939ad2e1 2026-10-01T11:32:22.023Z daily 0.9 https://www.dermfield.com/articles/only-3-of-korean-aesthetic-clinics-employ-an-anesthesiologist-f9a6934f 2026-10-01T11:32:21.891Z daily 0.9 https://www.dermfield.com/articles/sanofi-pays-regeneron-1b-upfront-to-build-next-gen-dupixent-successors-f1b11c0e 2026-10-01T09:00:41.435Z daily 0.9 https://www.dermfield.com/articles/glp-1-weight-loss-drugs-open-multi-billion-dollar-market-for-aesthetics-8f882c85 2026-10-01T15:23:14.620Z daily 0.9 https://www.dermfield.com/articles/provital-launches-kromboost-a-barley-derived-peptide-bioactive-for-hair-fibre-pr-453e2e22 2026-10-01T15:23:20.958Z daily 0.9 https://www.dermfield.com/articles/pfizer-s-tilrekimig-hits-skin-clearance-endpoint-in-phase-2-ad-trial-6eeff11d 2026-10-01T15:23:28.679Z daily 0.9 https://www.dermfield.com/articles/pfizer-phase-ii-results-advance-tilrekimig-into-pivotal-trials-fbbaa5ec 2026-10-01T15:23:43.049Z daily 0.9 https://www.dermfield.com/articles/skin-union-launches-targeting-skin-damage-linked-to-cancer-5c5998c2 2026-10-01T15:23:50.099Z daily 0.9 https://www.dermfield.com/articles/regeneron-and-sanofi-expand-immunology-partnership-in-deal-worth-up-to-8-billion-a107907d 2026-10-01T05:30:40.907Z daily 0.9 https://www.dermfield.com/articles/amorepacific-backs-junevity-s-gene-network-reset-platform-for-skin-rejuvenation-71c5ae80 2026-10-01T15:24:05.309Z daily 0.9 https://www.dermfield.com/articles/nine-members-of-congress-press-revlon-over-fda-talc-testing-failures-4354c366 2026-10-01T05:05:40.917Z daily 0.9 https://www.dermfield.com/articles/expert-consensus-maps-diagnosis-treatment-of-immunotherapy-skin-rashes-6b0585fa 2026-10-01T15:24:10.665Z daily 0.9 https://www.dermfield.com/articles/machine-learning-predicts-hyperglycemia-risk-in-psoriasis-69c5d884 2026-10-01T02:25:40.626Z daily 0.9 https://www.dermfield.com/articles/autonomous-ai-could-free-up-thousands-of-dermatology-slots-8336fc90 2026-10-01T15:24:16.562Z daily 0.9 https://www.dermfield.com/articles/lebrikizumab-improves-hand-and-foot-atopic-dermatitis-in-phase-3b-trial-f9b8cda4 2026-10-01T15:24:22.636Z daily 0.9 https://www.dermfield.com/articles/cureus-publishes-real-world-pro-data-on-aptos-thread-treatment-da06133f 2026-10-01T15:24:31.812Z daily 0.9 https://www.dermfield.com/articles/ai-guided-light-analysis-could-cut-unnecessary-skin-cancer-biopsies-9d8f7efc 2026-10-01T15:24:38.763Z daily 0.9 https://www.dermfield.com/articles/snowboard-legend-faces-possible-total-vision-loss-after-20-year-rare-cancer-batt-071c9f75 2026-10-01T15:24:44.763Z daily 0.9 https://www.dermfield.com/articles/multi-specific-biologics-take-aim-at-the-eczema-efficacy-gap-e8d16085 2026-10-01T15:25:00.759Z daily 0.9 https://www.dermfield.com/articles/94-7-of-viral-glass-skin-tiktok-videos-carry-misleading-claims-08162c46 2026-10-01T15:24:53.734Z daily 0.9 https://www.dermfield.com/articles/fda-finds-data-insufficient-to-judge-pfas-safety-in-cosmetics-b9dc14bf 2026-10-01T15:25:07.598Z daily 0.9 https://www.dermfield.com/articles/eadv-congress-2026-opens-six-day-one-headlines-for-dermatology-cb0d58d7 2026-09-30T18:45:48.201Z daily 0.9 https://www.dermfield.com/articles/aurobindo-pharma-s-acrotech-enters-us-dermatology-market-with-adquey-launch-93d65cd7 2026-10-01T15:25:15.089Z daily 0.9 https://www.dermfield.com/articles/cutaneous-melanoma-incidence-climbs-while-mortality-declines-8ff952fc 2026-09-30T17:45:40.532Z daily 0.9 https://www.dermfield.com/articles/zasocitinib-beats-deucravacitinib-in-phase-3-head-to-head-psoriasis-trial-ba3c7280 2026-10-01T15:25:22.524Z daily 0.9 https://www.dermfield.com/articles/acrotech-biopharma-launches-adquey-in-the-us-dermatology-market-94d38512 2026-09-30T17:15:23.464Z daily 0.9 https://www.dermfield.com/articles/tralokinumab-clears-high-impact-ad-areas-trace-real-world-data-show-be68af04 2026-09-30T16:45:23.086Z daily 0.9 https://www.dermfield.com/articles/zasocitinib-beats-deucravacitinib-head-to-head-in-phase-3-psoriasis-a0881fa2 2026-10-01T15:25:31.462Z daily 0.9 https://www.dermfield.com/articles/zumilokibart-hits-easi-75-endpoint-in-phase-2-ad-trial-4a0c2dfc 2026-10-01T15:25:45.758Z daily 0.9 https://www.dermfield.com/articles/rezpegaldesleukin-biomarker-data-show-early-immune-reset-in-ad-73a86cbd 2026-10-01T15:25:38.907Z daily 0.9 https://www.dermfield.com/articles/daxdilimab-improves-disease-activity-in-refractory-discoid-lupus-d1b6c429 2026-09-30T16:25:22.753Z daily 0.9 https://www.dermfield.com/articles/pdrn-goes-mass-from-l-oreal-to-primark-salmon-dna-ingredient-hits-609-8-growth-2f543484 2026-09-30T16:10:22.730Z daily 0.9 https://www.dermfield.com/articles/nektar-presents-biomarker-data-on-atopic-dermatitis-candidate-58311932 2026-10-01T15:25:51.923Z daily 0.9 https://www.dermfield.com/articles/ebglyss-hits-endpoints-in-phase-3b-hand-and-foot-atopic-dermatitis-trial-5a91a1fe 2026-10-01T15:25:59.088Z daily 0.9 https://www.dermfield.com/articles/raman-spectroscopy-plus-ai-classifies-bcc-scc-and-normal-skin-at-84-caff3368 2026-09-30T14:50:22.793Z daily 0.9 https://www.dermfield.com/articles/nektar-brings-early-biomarker-data-for-eczema-candidate-to-eadv-2026-d3cab414 2026-10-01T15:26:05.288Z daily 0.9 https://www.dermfield.com/articles/takeda-reports-zasocitinib-superior-to-deucravacitinib-029777a7 2026-09-30T14:10:22.330Z daily 0.9 https://www.dermfield.com/articles/lilly-s-ebglyss-meets-endpoints-in-phase-3b-hand-and-foot-ad-trial-d73196f6 2026-10-01T15:26:12.145Z daily 0.9 https://www.dermfield.com/articles/nemolizumab-shows-sustained-atopic-dermatitis-gains-at-152-weeks-in-arcadia-84ce3d1d 2026-10-01T15:26:19.975Z daily 0.9 https://www.dermfield.com/articles/bo-112-hits-primary-endpoint-in-phase-2b-basal-cell-carcinoma-trial-802c5336 2026-09-30T13:20:22.296Z daily 0.9 https://www.dermfield.com/articles/fau-researchers-pair-raman-spectroscopy-with-ai-for-skin-cancer-detection-2293c97c 2026-10-01T15:26:27.686Z daily 0.9 https://www.dermfield.com/articles/abbvie-moves-zumilokibart-into-phase-3-atopic-dermatitis-trials-fe487734 2026-09-30T12:10:22.159Z daily 0.9 https://www.dermfield.com/articles/lebrikizumab-shows-rapid-gains-in-hand-and-foot-atopic-dermatitis-9ebbc603 2026-10-01T15:26:33.528Z daily 0.9 https://www.dermfield.com/articles/zumilokibart-hits-easi-75-primary-endpoint-in-phase-2-atopic-dermatitis-trial-baa2d7c8 2026-10-01T15:26:39.986Z daily 0.9 https://www.dermfield.com/articles/abbvie-brings-60-dermatology-abstracts-to-2026-eadv-congress-f99b4631 2026-09-30T10:10:10.662Z daily 0.9 https://www.dermfield.com/articles/nemolizumab-shows-sustained-atopic-dermatitis-benefit-to-three-years-7ff024b5 2026-09-30T09:35:17.208Z daily 0.9 https://www.dermfield.com/articles/k-beauty-clinics-and-drugstores-prepare-for-golden-week-as-chinese-spending-tops-930cf81d 2026-10-01T15:26:45.773Z daily 0.9 https://www.dermfield.com/articles/abbvie-reports-positive-phase-2-apex-part-b-results-for-zumilokibart-8bdbdd16 2026-09-30T08:05:11.239Z daily 0.9 https://www.dermfield.com/articles/zumilokibart-hits-primary-endpoint-in-apex-part-b-atopic-dermatitis-trial-3d4a17fc 2026-10-01T15:26:59.358Z daily 0.9 https://www.dermfield.com/articles/korea-expands-europe-market-entry-support-for-dermatology-firms-7641ab28 2026-10-01T15:26:52.466Z daily 0.9 https://www.dermfield.com/articles/medical-aesthetics-enters-a-new-era-of-rules-and-standards-697e07cc 2026-09-30T08:00:11.418Z daily 0.9 https://www.dermfield.com/articles/misinformation-dominates-viral-korean-skincare-content-on-tiktok-7335c506 2026-10-01T15:27:04.995Z daily 0.9 https://www.dermfield.com/articles/atopic-dermatitis-raises-herpes-zoster-risk-28-in-13-million-person-uk-cohort-09073721 2026-09-30T07:05:13.336Z daily 0.9 https://www.dermfield.com/articles/solar-simulated-uvb-plus-uva-alters-the-skin-microbiome-exploratory-data-94966cc2 2026-10-01T15:27:10.452Z daily 0.9 https://www.dermfield.com/articles/abbvie-s-zumilokibart-hits-phase-2-atopic-dermatitis-endpoint-0b406310 2026-09-30T06:05:10.262Z daily 0.9 https://www.dermfield.com/articles/nemolizumab-sustains-atopic-dermatitis-improvements-through-three-years-6e5bad8c 2026-09-30T06:05:10.226Z daily 0.9 https://www.dermfield.com/articles/zumilokibart-clears-phase-2-in-atopic-dermatitis-moves-to-phase-3-d6cbec47 2026-09-30T06:05:10.262Z daily 0.9 https://www.dermfield.com/articles/nemolizumab-shows-sustained-response-up-to-three-years-in-atopic-dermatitis-aa6ec97d 2026-10-01T15:27:16.465Z daily 0.9 https://www.dermfield.com/articles/zasocitinib-beats-deucravacitinib-in-phase-3-head-to-head-trial-1b9811ef 2026-09-30T05:35:09.927Z daily 0.9 https://www.dermfield.com/articles/aada-backs-new-york-city-council-medspa-investigation-6988b477 2026-10-01T15:27:22.230Z daily 0.9 https://www.dermfield.com/articles/pdrn-serums-under-the-microscope-dermatology-times-weighs-in-1296bb3b 2026-10-01T15:27:29.630Z daily 0.9 https://www.dermfield.com/articles/gutskin-microbiome-pathways-move-to-the-center-of-vitiligo-research-dfaf7a7b 2026-10-01T15:27:36.350Z daily 0.9 https://www.dermfield.com/articles/dermatology-fda-and-pipeline-review-q3-2026-approvals-and-readouts-a4edea75 2026-10-01T15:27:43.382Z daily 0.9 https://www.dermfield.com/articles/south-devon-nhs-event-puts-local-skin-cancer-risk-in-focus-d35f7aba 2026-09-30T04:10:09.443Z daily 0.9 https://www.dermfield.com/articles/genentech-returns-melanoma-asset-to-hanmi-korean-trials-next-33baafa5 2026-10-01T15:27:50.162Z daily 0.9 https://www.dermfield.com/articles/prospective-study-profiles-infantile-dermatoses-in-rural-north-india-59514ae6 2026-10-01T15:27:57.030Z daily 0.9 https://www.dermfield.com/articles/hugel-names-taiwan-a-key-growth-market-for-letybo-aesthetic-push-8af97b6d 2026-09-29T23:25:08.730Z daily 0.9 https://www.dermfield.com/articles/autonomous-ai-could-unlock-thousands-of-extra-dermatology-appointments-38baab3b 2026-09-29T22:25:07.936Z daily 0.9 https://www.dermfield.com/articles/fda-approves-icotrokinra-first-oral-targeted-peptide-for-plaque-psoriasis-aa5528ac 2026-09-29T20:55:07.824Z daily 0.9 https://www.dermfield.com/articles/biologics-in-dermatology-patients-with-malignancy-risk-3d2b8dcf 2026-09-29T20:55:07.808Z daily 0.9 https://www.dermfield.com/articles/4-3-patch-test-positivity-for-ppd-allergy-in-7-year-review-7d880262 2026-09-29T19:25:07.028Z daily 0.9 https://www.dermfield.com/articles/generalized-pustular-psoriasis-review-maps-current-and-emerging-therapies-68044496 2026-09-29T18:53:24.977Z daily 0.9 https://www.dermfield.com/articles/dysfunction-not-absence-of-immune-cells-defines-skin-cancer-risk-93f165b8 2026-09-29T18:25:08.231Z daily 0.9 https://www.dermfield.com/articles/investigational-drug-shows-early-promise-in-nras-mutant-melanoma-a294114a 2026-09-29T18:20:06.649Z daily 0.9 https://www.dermfield.com/articles/xeligekimab-clears-refractory-generalized-pustular-psoriasis-in-two-cases-3548f1e0 2026-09-29T18:20:06.637Z daily 0.9 https://www.dermfield.com/articles/oral-therapies-position-to-reshape-psoriasis-and-psa-care-022bfed3 2026-09-29T18:20:06.649Z daily 0.9 https://www.dermfield.com/articles/fda-accepts-bla-for-imsidolimab-in-generalized-pustular-psoriasis-a8a24a39 2026-09-29T18:20:13.269Z daily 0.9 https://www.dermfield.com/articles/biosimilar-ct-p43-matches-ustekinumab-for-moderate-to-severe-plaque-psoriasis-75377212 2026-09-29T18:15:08.060Z daily 0.9 https://www.dermfield.com/articles/cd169-positive-macrophages-identified-as-local-brake-on-cutaneous-melanoma-growt-5e14da68 2026-09-29T18:53:44.491Z daily 0.9 https://www.dermfield.com/articles/personalized-melanoma-vaccine-holds-49-recession-reduction-at-5-years-db913ab7 2026-09-29T18:53:31.463Z daily 0.9 https://www.dermfield.com/articles/fda-approves-icotrokinra-first-targeted-oral-peptide-for-plaque-psoriasis-a214bea1 2026-09-29T18:53:38.020Z daily 0.9 https://www.dermfield.com/articles/immunocore-melanoma-pipeline-data-loom-large-for-investors-7db5ceff 2026-09-29T18:10:05.976Z daily 0.9 https://www.dermfield.com/articles/molecular-imaging-could-cut-melanoma-biopsy-volumes-3ed4d9e6 2026-09-29T18:10:05.923Z daily 0.9 https://www.dermfield.com/articles/high-dose-risankizumab-shows-fast-durable-psoriasis-response-f2b40184 2026-09-29T18:54:14.546Z daily 0.9 https://www.dermfield.com/articles/how-advances-in-therapy-are-changing-skin-cancer-care-466d645f 2026-09-29T18:53:49.922Z daily 0.9 https://www.dermfield.com/articles/tempo-therapeutics-wins-2-25m-nih-sbir-grant-for-map-wound-healing-6e42333f 2026-09-29T18:54:08.742Z daily 0.9 https://www.dermfield.com/articles/newly-approved-oral-psoriasis-therapy-expands-treatment-options-de95d532 2026-09-29T18:53:57.066Z daily 0.9 https://www.dermfield.com/articles/the-barbie-peptide-tanning-trend-is-a-warning-not-a-dreamhouse-8935f7aa 2026-09-29T18:05:06.247Z daily 0.9 https://www.dermfield.com/articles/immunotherapy-shows-promise-for-clearing-residual-melanoma-cells-8bd826aa 2026-09-29T18:54:02.811Z daily 0.9 https://www.dermfield.com/articles/fda-approves-icotrokinra-first-oral-il-23-receptor-blocker-for-psoriasis-c1103374 2026-09-29T18:05:06.247Z daily 0.9 https://www.dermfield.com/articles/fda-approves-j-j-s-icotyde-for-plaque-psoriasis-b9f87a2b 2026-09-29T18:05:06.247Z daily 0.9 https://www.dermfield.com/articles/moderna-brings-more-melanoma-trial-data-to-esmo-congress-67999e4e 2026-09-29T18:05:06.247Z daily 0.9 https://www.dermfield.com/articles/zasocitinib-clears-psoriasis-at-hardest-to-treat-sites-in-once-daily-pill-ff48b4e2 2026-09-29T18:00:34.313Z daily 0.9 https://www.dermfield.com/articles/immunogenetics-is-reshaping-psoriasis-diagnosis-and-treatment-563061ab 2026-09-29T18:00:46.171Z daily 0.9 https://www.dermfield.com/articles/early-secukinumab-initiation-tied-to-durable-psoriasis-control-7d655a66 2026-09-29T18:00:40.573Z daily 0.9 https://www.dermfield.com/articles/usf-antarctica-expedition-advances-potential-melanoma-treatment-research-a402425a 2026-09-29T18:00:15.673Z daily 0.9 https://www.dermfield.com/articles/personalized-melanoma-vaccine-cuts-recurrence-risk-in-phase-3-7ceb96f1 2026-09-29T18:00:15.673Z daily 0.9 https://www.dermfield.com/articles/myc-emerges-as-a-key-therapeutic-target-in-melanoma-5691beff 2026-09-29T18:00:52.502Z daily 0.9 https://www.dermfield.com/articles/v-foundation-funds-aging-focused-melanoma-research-at-fox-chase-18d04cdc 2026-09-29T18:01:16.955Z daily 0.9 https://www.dermfield.com/articles/zif-8-nanocarrier-targets-melanoma-with-plant-drug-and-gold-nanorods-defd2298 2026-09-29T17:55:07.371Z daily 0.9 https://www.dermfield.com/articles/acral-melanoma-presents-with-multiple-intussusceptions-in-case-report-0d4efc29 2026-09-29T18:00:58.464Z daily 0.9 https://www.dermfield.com/articles/fda-advisory-committee-backs-melanoma-therapy-after-two-rejections-53c15bf7 2026-09-29T17:55:07.371Z daily 0.9 https://www.dermfield.com/articles/yankees-to-offer-free-pregame-skin-cancer-screenings-at-stadium-9b3330c1 2026-09-29T17:55:07.371Z daily 0.9 https://www.dermfield.com/articles/personalized-melanoma-vaccine-cuts-recurrence-risk-at-five-years-f5dc244b 2026-09-29T18:01:04.300Z daily 0.9 https://www.dermfield.com/articles/largest-ever-genetic-study-of-moles-offers-new-clues-to-melanoma-0944a062 2026-09-29T18:01:10.677Z daily 0.9 https://www.dermfield.com/articles/adjuvant-melanoma-drug-cuts-recurrence-risk-in-reported-trial-a13590d8 2026-09-29T17:50:05.665Z daily 0.9 https://www.dermfield.com/articles/pfas-exposure-linked-to-higher-nonmelanoma-skin-cancer-risk-da196150 2026-09-29T18:01:29.295Z daily 0.9 https://www.dermfield.com/articles/skinformer-hybrid-ai-detects-and-segments-skin-cancer-60d00b4f 2026-09-29T18:01:36.289Z daily 0.9 https://www.dermfield.com/articles/nyu-langone-team-identifies-molecule-driving-skin-cancer-growth-576ad450 2026-09-29T18:01:42.318Z daily 0.9 https://www.dermfield.com/articles/nature-publishes-prism-framework-for-multimodal-skin-cancer-diagnosis-d8b0fb45 2026-09-29T17:45:06.654Z daily 0.9 https://www.dermfield.com/articles/nature-study-late-fusion-of-pretrained-models-for-skin-cancer-detection-3b16a98d 2026-09-29T17:45:06.654Z daily 0.9 https://www.dermfield.com/articles/long-term-cohort-study-links-tnf-inhibitors-to-skin-cancer-risk-d282e22f 2026-09-29T18:01:48.064Z daily 0.9 https://www.dermfield.com/articles/barzolvolimab-hits-all-phase-3-end-points-in-chronic-spontaneous-urticaria-cdc9f903 2026-09-29T17:45:06.654Z daily 0.9 https://www.dermfield.com/articles/building-a-hidradenitis-suppurativa-toolkit-for-unpredictable-flares-11bdee57 2026-09-29T17:43:32.696Z daily 0.9 https://www.dermfield.com/articles/vusolimogene-oderparepvec-secures-approval-for-advanced-melanoma-7daff310 2026-09-29T17:20:05.379Z daily 0.9 https://www.dermfield.com/articles/simone-biles-goes-public-about-her-eczema-journey-d9cf06c0 2026-09-29T17:43:39.866Z daily 0.9 https://www.dermfield.com/articles/iovance-shares-jump-on-rising-demand-for-melanoma-cell-therapy-fbaf945a 2026-09-29T16:20:05.839Z daily 0.9 https://www.dermfield.com/articles/iovance-shares-jump-on-rising-demand-for-melanoma-cell-therapy-bd4172f3 2026-09-29T17:43:46.718Z daily 0.9 https://www.dermfield.com/articles/medscape-case-challenge-dark-spot-on-a-10-year-old-s-hand-dcb36c3d 2026-09-29T17:43:59.767Z daily 0.9 https://www.dermfield.com/articles/mediterranean-diet-linked-to-lower-acne-likelihood-in-adults-2a291cd9 2026-09-29T17:44:06.787Z daily 0.9 https://www.dermfield.com/articles/single-day-hands-on-dermatology-workshop-boosts-student-knowledge-confidence-c8405e8e 2026-09-29T17:44:13.371Z daily 0.9 https://www.dermfield.com/articles/dermatologist-elected-chair-of-house-health-panel-27f447d0 2026-09-29T13:10:02.192Z daily 0.9 https://www.dermfield.com/articles/scalp-botox-for-hair-loss-doctors-assess-south-korea-s-latest-trend-28ecd0e6 2026-09-29T12:40:01.511Z daily 0.9 https://www.dermfield.com/articles/assessing-severity-and-biologic-barriers-in-hidradenitis-suppurativa-5bfa699c 2026-09-29T12:41:05.442Z daily 0.9 https://www.dermfield.com/articles/is-pasi-75-still-the-gold-standard-for-psoriasis-e1dad65d 2026-09-29T12:05:01.426Z daily 0.9 https://www.dermfield.com/articles/cureus-publishes-study-on-dermoscopy-in-hypopigmentation-disorders-490a2b6c 2026-09-29T12:06:13.919Z daily 0.9 https://www.dermfield.com/articles/p-g-drops-hair-free-for-two-years-claims-on-braun-ipl-device-83640c81 2026-09-29T10:55:01.362Z daily 0.9 https://www.dermfield.com/articles/teoxane-positions-itself-around-an-integrated-aesthetics-model-0c193dd6 2026-09-29T07:33:08.353Z daily 0.9 https://www.dermfield.com/articles/discovery-may-open-new-treatment-paths-for-skin-cancer-in-immunosuppressed-patie-10bd53e8 2026-09-29T06:53:08.290Z daily 0.9 https://www.dermfield.com/articles/mrna-drug-shows-breakthrough-potential-in-deadly-skin-cancer-5bc57c39 2026-09-29T00:13:14.934Z daily 0.9 https://www.dermfield.com/articles/amlitelimab-for-atopic-dermatitis-derm-immuno-today-segment-866b772b 2026-09-29T17:44:19.569Z daily 0.9 https://www.dermfield.com/articles/p53-isoforms-show-heterogeneous-tumor-suppressor-roles-in-uveal-melanoma-746e9785 2026-09-29T17:44:31.264Z daily 0.9 https://www.dermfield.com/articles/medscape-projects-melanoma-case-increase-for-2026-6d18dbc2 2026-09-28T20:43:14.712Z daily 0.9 https://www.dermfield.com/articles/low-dietary-diversity-in-infancy-linked-to-atopic-dermatitis-risk-540e6a24 2026-09-29T17:44:25.344Z daily 0.9 https://www.dermfield.com/articles/biomarkers-advance-severity-tracking-in-pediatric-atopic-dermatitis-95e4524c 2026-09-28T18:08:14.635Z daily 0.9 https://www.dermfield.com/articles/red-light-therapy-what-dermatology-can-and-cannot-claim-ac0fd788 2026-09-29T17:44:38.381Z daily 0.9 https://www.dermfield.com/articles/alopecia-areata-awareness-month-2026-in-review-873f8247 2026-09-28T15:38:14.502Z daily 0.9 https://www.dermfield.com/articles/skin-lightening-products-under-scrutiny-a-pharmacist-facing-risk-review-7e3c20b1 2026-09-29T17:44:44.173Z daily 0.9 https://www.dermfield.com/articles/gentlecure-reaches-150-000th-patient-treated-for-common-skin-cancer-166550b4 2026-09-28T15:03:14.519Z daily 0.9 https://www.dermfield.com/articles/nektar-to-present-three-rezpegaldesleukin-orals-at-eadv-2026-35fab0dc 2026-09-29T17:44:53.747Z daily 0.9 https://www.dermfield.com/articles/dick-vitale-85-vows-to-keep-fighting-after-melanoma-diagnosis-feb13b4d 2026-09-28T13:38:14.331Z daily 0.9 https://www.dermfield.com/articles/case-review-systemic-naive-patient-with-occupational-plaque-psoriasis-ca2ea5dc 2026-09-28T12:33:14.263Z daily 0.9 https://www.dermfield.com/articles/fda-approval-of-ameluz-expands-skin-cancer-treatment-options-bf0340e0 2026-09-29T17:44:59.841Z daily 0.9 https://www.dermfield.com/articles/dupilumab-shows-effectiveness-in-paediatric-atopic-dermatitis-d52463b9 2026-09-28T10:33:14.208Z daily 0.9 https://www.dermfield.com/articles/vitiligo-onset-during-dupilumab-therapy-in-a-child-with-atopic-dermatitis-733820ae 2026-09-28T10:33:14.216Z daily 0.9 https://www.dermfield.com/articles/age-shapes-dupilumab-s-quality-of-life-gains-in-children-7c77d875 2026-09-28T10:03:14.191Z daily 0.9 https://www.dermfield.com/articles/medytox-secures-nmpa-approval-for-neuramis-dermal-filler-in-china-35b7a98a 2026-09-29T17:45:09.168Z daily 0.9 https://www.dermfield.com/articles/dermatology-s-skin-equity-goal-hinges-on-targeted-strategies-759315fe 2026-09-29T17:45:15.418Z daily 0.9 https://www.dermfield.com/articles/atopic-dermatitis-treatment-burnout-draws-clinical-attention-d35813ae 2026-09-28T07:28:14.022Z daily 0.9 https://www.dermfield.com/articles/canterbury-skin-cancer-programme-builds-on-waitlist-progress-59852fa5 2026-09-29T17:45:22.135Z daily 0.9 https://www.dermfield.com/articles/review-maps-parents-experience-of-raising-a-child-with-atopic-dermatitis-02eee846 2026-09-28T07:28:13.995Z daily 0.9 https://www.dermfield.com/articles/one-third-of-pediatric-dermatology-fellowship-programs-fail-to-match-8c641bb6 2026-09-29T17:45:27.776Z daily 0.9 https://www.dermfield.com/articles/texas-southmost-college-to-launch-medical-aesthetics-certificate-12b0b2b9 2026-09-28T06:28:13.925Z daily 0.9 https://www.dermfield.com/articles/modernamerck-melanoma-combo-cuts-spread-risk-at-five-years-c0514991 2026-09-28T06:28:13.925Z daily 0.9 https://www.dermfield.com/articles/the-lancet-publishes-phase-3-data-on-rocatinlimab-in-atopic-dermatitis-884e9f23 2026-09-28T04:58:13.789Z daily 0.9 https://www.dermfield.com/articles/dermcare-management-and-u-s-dermatology-partners-complete-merger-c252a21c 2026-09-29T17:45:33.750Z daily 0.9 https://www.dermfield.com/articles/pharmaresearch-launches-rejuran-in-hungary-extending-european-reach-b3cbf913 2026-09-29T17:45:40.790Z daily 0.9 https://www.dermfield.com/articles/melanoma-at-23-the-case-that-challenges-sun-safety-assumptions-a376ec28 2026-09-28T03:58:13.687Z daily 0.9 https://www.dermfield.com/articles/rare-skin-cancer-presents-as-an-itchy-rash-not-a-tumor-1269498e 2026-09-29T17:45:46.702Z daily 0.9 https://www.dermfield.com/articles/sheffield-skin-cancer-patient-launches-free-sun-cream-scheme-6028acb1 2026-09-28T02:23:13.563Z daily 0.9 https://www.dermfield.com/articles/immune-cell-profiles-may-predict-skin-cancer-treatment-outcomes-9c31667a 2026-09-29T17:45:59.339Z daily 0.9 https://www.dermfield.com/articles/could-barbers-become-frontline-partners-in-skin-cancer-detection-ebdb6173 2026-09-28T02:23:13.594Z daily 0.9 https://www.dermfield.com/articles/uk-melanoma-diagnoses-reach-record-high-cancer-research-uk-reports-8f87ed3f 2026-09-28T02:23:13.594Z daily 0.9 https://www.dermfield.com/articles/skin-cancer-prevention-could-substantially-lower-health-care-costs-baf18c5e 2026-09-28T02:23:13.594Z daily 0.9 https://www.dermfield.com/articles/cancer-research-uk-launches-prevention-study-for-high-risk-skin-cancer-groups-e3d8a92b 2026-09-29T17:45:52.399Z daily 0.9 https://www.dermfield.com/articles/poly-l-lactic-acid-in-facial-rejuvenation-clinical-data-under-review-bab62e3b 2026-09-28T00:23:13.306Z daily 0.9 https://www.dermfield.com/articles/moderna-shares-surge-29-1-on-melanoma-vaccine-data-1c0a4a31 2026-09-29T17:46:06.629Z daily 0.9 https://www.dermfield.com/articles/chinese-made-atopic-dermatitis-drugs-show-incredible-response-rates-ef126df9 2026-09-29T17:46:18.390Z daily 0.9 https://www.dermfield.com/articles/glp-1-receptor-agonist-added-to-biologic-therapy-improved-quality-of-life-in-pso-2e99c864 2026-09-29T17:46:12.406Z daily 0.9 https://www.dermfield.com/articles/tachyphylaxis-in-psoriasis-what-s-really-happening-bcd0a25d 2026-09-27T20:23:13.037Z daily 0.9 https://www.dermfield.com/articles/3d-models-and-smoke-evacuators-lift-mohs-surgery-patient-satisfaction-47ff7b8a 2026-09-29T17:46:24.858Z daily 0.9 https://www.dermfield.com/articles/samyang-biopharm-launches-lafullen-filler-in-thailand-b6a12dc7 2026-09-29T17:46:30.384Z daily 0.9 https://www.dermfield.com/articles/ontario-s-botox-boom-exposes-provider-divide-47f518f5 2026-09-29T17:46:36.788Z daily 0.9 https://www.dermfield.com/articles/seasonal-boundaries-blur-in-china-s-photonic-aesthetic-device-market-836781d8 2026-09-27T19:18:12.967Z daily 0.9 https://www.dermfield.com/articles/medytox-secures-china-approval-for-neuramis-dermal-filler-6a95ce1a 2026-09-27T19:18:12.967Z daily 0.9 https://www.dermfield.com/articles/huons-meditech-takes-aesthetic-device-portfolio-to-amuse-2026-in-indonesia-20f2553d 2026-09-27T19:18:12.967Z daily 0.9 https://www.dermfield.com/articles/dermatology-appointment-access-as-a-mirror-of-systemic-healthcare-gaps-847f5b0d 2026-09-27T19:18:12.967Z daily 0.9 https://www.dermfield.com/articles/bimekizumab-delivers-response-in-two-hard-to-treat-psoriasis-cases-0aab3039 2026-09-27T18:48:12.912Z daily 0.9 https://www.dermfield.com/articles/telehealth-matches-in-person-visits-for-atopic-dermatitis-quality-of-life-2207655f 2026-09-29T17:46:42.151Z daily 0.9 https://www.dermfield.com/articles/teen-campaign-warns-tanmaxxing-is-skin-cancer-maxxing-92f6a1f3 2026-09-29T17:46:48.041Z daily 0.9 https://www.dermfield.com/articles/emj-asks-whether-red-light-therapy-marketing-claims-survive-scrutiny-ffec88ad 2026-09-29T17:46:55.287Z daily 0.9 https://www.dermfield.com/articles/crepey-skin-with-age-what-new-research-says-and-what-can-be-done-70cda3e2 2026-09-27T16:18:12.779Z daily 0.9 https://www.dermfield.com/articles/strain-level-warfare-limits-coexistence-in-skin-microbiomes-f7436ac6 2026-09-27T14:43:12.596Z daily 0.9 https://www.dermfield.com/articles/tanning-beds-triple-melanoma-risk-northwestern-data-show-466c864d 2026-09-29T17:47:01.128Z daily 0.9 https://www.dermfield.com/articles/relevant-contact-allergy-found-in-41-of-hand-eczema-cases-referred-for-testing-a90a84c2 2026-09-29T17:47:07.241Z daily 0.9 https://www.dermfield.com/articles/teen-attitudes-toward-sun-protection-shape-skin-cancer-prevention-7e302a62 2026-09-29T17:47:23.966Z daily 0.9 https://www.dermfield.com/articles/regeneron-shares-fall-as-skin-cancer-therapy-misses-in-late-stage-trial-5612e830 2026-09-29T17:47:31.241Z daily 0.9 https://www.dermfield.com/articles/skin-metatranscriptomics-maps-microbial-activity-across-body-sites-6b3a8da3 2026-09-27T08:08:12.140Z daily 0.9 https://www.dermfield.com/articles/aad-releases-new-guidelines-for-pediatric-atopic-dermatitis-care-10389227 2026-09-29T17:47:37.770Z daily 0.9 https://www.dermfield.com/articles/dermoscopy-based-models-predict-melanoma-metastasis-in-reader-study-0831c59c 2026-09-27T06:38:12.065Z daily 0.9 https://www.dermfield.com/articles/rhenium-188-epidermal-radionuclide-therapy-in-non-melanoma-skin-cancer-0f50feea 2026-09-27T06:08:11.979Z daily 0.9 https://www.dermfield.com/articles/personalized-mrna-vaccines-move-into-the-melanoma-fight-1827687c 2026-09-27T03:03:11.742Z daily 0.9 https://www.dermfield.com/articles/updated-atopic-dermatitis-guidelines-urge-proactive-personalized-care-26b02621 2026-09-29T17:47:43.958Z daily 0.9 https://www.dermfield.com/articles/moderna-shares-jump-on-melanoma-vaccine-trial-readout-0a9ccc20 2026-09-29T17:47:58.704Z daily 0.9 https://www.dermfield.com/articles/atopic-dermatitis-wound-care-draws-new-attention-caec5528 2026-09-29T17:47:50.743Z daily 0.9 https://www.dermfield.com/articles/ucla-study-identifies-factors-shaping-immunotherapy-response-in-advanced-melanom-60d3250b 2026-09-29T17:48:05.915Z daily 0.9 https://www.dermfield.com/articles/military-aviators-face-elevated-skin-cancer-risk-study-finds-08ad12d8 2026-09-29T17:48:12.457Z daily 0.9 https://www.dermfield.com/articles/dermatology-ai-has-arrived-integration-is-the-next-challenge-693b9bb4 2026-09-26T21:28:11.123Z daily 0.9 https://www.dermfield.com/articles/ai-driven-3d-total-body-photography-advances-skin-cancer-surveillance-e5824622 2026-09-29T17:48:32.304Z daily 0.9 https://www.dermfield.com/articles/mount-nittany-buys-2-3m-building-to-expand-dermatology-services-4e1975a2 2026-09-29T17:48:18.499Z daily 0.9 https://www.dermfield.com/articles/andrew-alexis-md-mph-new-therapies-reshape-skin-of-color-care-bc2e1000 2026-09-29T17:48:24.979Z daily 0.9 https://www.dermfield.com/articles/people-of-color-and-atopic-dermatitis-trials-what-to-know-f4f2a08a 2026-09-26T20:58:11.146Z daily 0.9 https://www.dermfield.com/articles/hypereosinophilic-syndrome-masked-as-refractory-atopic-dermatitis-9d43679b 2026-09-29T17:49:08.883Z daily 0.9 https://www.dermfield.com/articles/infant-skin-microbiome-shifts-may-forecast-eczema-food-allergy-b026b878 2026-09-26T09:18:31.164Z daily 0.9 https://www.dermfield.com/articles/grappa-publishes-consensus-definitions-for-difficult-to-treat-psoriatic-arthriti-55518f66 2026-09-29T17:48:40.609Z daily 0.9 https://www.dermfield.com/articles/christopher-m-hull-md-named-interim-chair-of-dermatology-at-university-of-utah-h-e4ecdeac 2026-09-29T17:49:01.616Z daily 0.9 https://www.dermfield.com/articles/lilly-psoriasis-trial-backs-immunometabolic-treatment-strategy-e39e4d5b 2026-09-29T17:48:54.392Z daily 0.9 https://www.dermfield.com/articles/moderna-stock-jumps-9-on-phase-3-melanoma-slot-at-symposium-2481f186 2026-09-29T17:49:15.347Z daily 0.9 https://www.dermfield.com/articles/tattooing-linked-to-lymphoma-and-skin-cancer-risk-03de7b93 2026-09-29T17:50:42.481Z daily 0.9 https://www.dermfield.com/articles/lilly-s-zepbound-plus-taltz-improved-psoriasis-weight-in-study-8f64817b 2026-09-29T17:50:36.054Z daily 0.9 https://www.dermfield.com/articles/uc-san-diego-researchers-flag-natural-molecule-in-melanoma-strategy-b8b57869 2026-09-29T12:06:33.359Z daily 0.9 https://www.dermfield.com/articles/preclinical-data-suggest-new-cream-may-slow-common-skin-cancers-b7dc5607 2026-09-29T17:50:00.886Z daily 0.9 https://www.dermfield.com/articles/early-and-late-onset-psoriasis-may-call-for-different-protocols-d19f210c 2026-09-29T12:07:59.158Z daily 0.9 https://www.dermfield.com/articles/fda-approves-oral-psoriasis-pill-developed-with-uq-research-4fb367c1 2026-09-26T08:59:35.228Z daily 0.9 https://www.dermfield.com/articles/moderna-and-merck-cancer-vaccine-breakthrough-reported-339acbcd 2026-09-29T12:06:20.012Z daily 0.9 https://www.dermfield.com/articles/nature-paper-maps-path-to-clinical-ai-triage-for-skin-cancer-5fa50653 2026-09-29T12:07:18.095Z daily 0.9 https://www.dermfield.com/articles/mrna-cancer-vaccine-plus-keytruda-boosts-melanoma-survival-f23e97a5 2026-09-29T12:06:59.215Z daily 0.9 https://www.dermfield.com/articles/dermatology-practices-absorb-rising-prior-authorization-costs-32dcfe60 2026-09-29T12:07:39.467Z daily 0.9 https://www.dermfield.com/articles/uthsc-names-dr-tejesh-patel-dual-chair-of-pathology-and-dermatology-35e242b3 2026-09-29T17:50:23.157Z daily 0.9 https://www.dermfield.com/articles/fda-approves-icotrokinra-first-oral-il-23-inhibitor-for-plaque-psoriasis-5f96d80c 2026-09-29T12:06:26.678Z daily 0.9 https://www.dermfield.com/articles/family-gift-to-unm-aims-to-widen-dermatology-access-in-new-mexico-273aaf01 2026-09-29T12:08:11.133Z daily 0.9 https://www.dermfield.com/articles/melanoma-vaccine-candidate-shows-promise-what-dermatologists-know-f2ed688f 2026-09-29T17:49:54.518Z daily 0.9 https://www.dermfield.com/articles/uconn-s-dr-jane-m-grant-kels-elected-aad-president-elect-d26dd87f 2026-09-26T08:59:35.028Z daily 0.9 https://www.dermfield.com/articles/va-researchers-identify-potential-new-melanoma-treatment-pathway-30541a9e 2026-09-29T12:07:11.422Z daily 0.9 https://www.dermfield.com/articles/temperature-defined-seasonality-may-shape-psoriasis-treatment-outcomes-988ad603 2026-09-26T08:59:35.317Z daily 0.9 https://www.dermfield.com/articles/hawaii-faces-physician-shortage-yet-dermatology-stays-well-staffed-65a9debf 2026-09-26T08:59:35.916Z daily 0.9 https://www.dermfield.com/articles/tanning-bed-use-resurging-fresno-dermatologist-warns-cf4d2633 2026-09-29T17:50:29.223Z daily 0.9 https://www.dermfield.com/articles/nih-genetic-testing-may-benefit-more-patients-with-melanoma-153be9c3 2026-09-29T12:08:04.948Z daily 0.9 https://www.dermfield.com/articles/nicotinamide-shows-promise-in-reducing-skin-cancer-development-f84e0dfe 2026-09-29T12:07:53.693Z daily 0.9 https://www.dermfield.com/articles/fda-approves-icotyde-for-moderate-to-severe-plaque-psoriasis-7ebf97f1 2026-09-26T08:59:35.916Z daily 0.9 https://www.dermfield.com/articles/evaluating-treatment-selection-in-psoriasis-e016a689 2026-09-26T08:59:35.228Z daily 0.9 https://www.dermfield.com/articles/italian-multicenter-study-assesses-ixekizumab-in-psoriatic-arthritis-652023a3 2026-09-29T17:49:35.573Z daily 0.9 https://www.dermfield.com/articles/cbl-identified-as-new-driver-gene-in-stage-ii-melanoma-bc1d9559 2026-09-29T17:49:29.612Z daily 0.9 https://www.dermfield.com/articles/fda-clears-baricitinib-for-adolescents-with-severe-alopecia-areata-d8c214f6 2026-09-29T12:07:32.806Z daily 0.9 https://www.dermfield.com/articles/upadacitinib-shows-efficacy-in-psoriasis-coexisting-with-lichen-planus-045531e3 2026-09-26T08:59:35.228Z daily 0.9 https://www.dermfield.com/articles/naturally-occurring-molecule-may-help-outsmart-melanoma-uc-researchers-say-bec85816 2026-09-29T12:08:17.485Z daily 0.9 https://www.dermfield.com/articles/circulating-micrornas-as-melanoma-biomarkers-systematic-review-222d8c4b 2026-09-29T12:07:05.384Z daily 0.9 https://www.dermfield.com/articles/heidi-jacobe-appointed-chair-of-dermatology-at-duke-f3990004 2026-09-29T17:49:22.905Z daily 0.9 https://www.dermfield.com/articles/nicotinamide-linked-to-lower-melanoma-risk-after-skin-cancer-d081e231 2026-09-29T12:06:39.351Z daily 0.9 https://www.dermfield.com/articles/melanoma-vaccine-cuts-recurrence-risk-in-landmark-trial-62950fe2 2026-09-29T17:49:43.228Z daily 0.9 https://www.dermfield.com/articles/personalized-mrna-cancer-vaccine-emerges-in-melanoma-fight-6a269269 2026-09-26T08:59:35.916Z daily 0.9 https://www.dermfield.com/articles/kybella-label-updated-with-warnings-on-off-label-use-and-persistent-nodules-1747f473 2026-09-29T12:07:46.900Z daily 0.9 https://www.dermfield.com/articles/reimbursement-erosion-is-reshaping-dermatology-practice-3ff7dc1c 2026-09-26T08:59:35.916Z daily 0.9 https://www.dermfield.com/articles/risankizumab-clears-persistent-facial-plaque-psoriasis-in-case-report-99693176 2026-09-26T08:59:35.317Z daily 0.9 https://www.dermfield.com/articles/penn-tests-mrna-cancer-vaccine-what-dermatology-should-watch-55a3cd5b 2026-09-29T12:06:45.839Z daily 0.9 https://www.dermfield.com/articles/moderna-and-merck-revive-mrna-prospects-with-melanoma-success-50ce65c8 2026-09-29T17:49:48.827Z daily 0.9 https://www.dermfield.com/articles/lymph-node-colonization-drives-tumor-evolution-study-suggests-921fd675 2026-09-29T17:50:08.888Z daily 0.9 https://www.dermfield.com/articles/anhydroicaritin-loaded-stem-cell-exosomes-ease-psoriasis-in-mice-b1410cfb 2026-09-29T17:50:16.838Z daily 0.9